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1  Introduction 
 
1.1 Radiation-induced pneumopathy and its pathology 
 
Radiation-induced pneumopathy constitutes a dose-limiting adverse effect of thorax irradiation 
for the treatment of malignancies in the thoracic area, such as lung, breast or hematologic 
malignancies, as well as for whole body irradiation as part of the preconditioning before bone 
marrow transplantation. In general, the risk of radiation-induced side effects and the severity of 
lung injury are directly related to the irradiated tissue volume, the total radiation dose delivered, 
the dose rate, and concurrent chemotherapy applied (Gross, 1977; Jennings and Arden, 1961). 
Albeit many progresses have been made in the field of radiotherapy, this therapeutic 
intervention has still to cope with a critical dilemma: the contrast between the intrinsic 
radioresistance of malignant tumors and the high radiosensitivity of lung tissue, which is 
characterized by low regenerative capacity. 
 
Radiation-induced pneumopathy has been intensively studied and, with respect to time-related 
reactions, cytotoxic effects of ionizing radiation (IR) have been differentiated in radiation 
pneumonitis and radiation fibrosis, considered as two types of lung injury that are not 
necessarily connected (Gross, 1977; Morgan and Breit, 1995). Radiation pneumonitis occurs 1 
to 3 months following irradiation, with an incidence that ranges from 10 to 20 % of treated 
patients. Common clinical manifestations include dry cough, dyspnea and fever. Occasionally 
and depending on the severity and duration of the early effects, resolution and a full restoration 
of the normal tissue functions can occur (Davis et al., 1992; Ghafoori et al., 2008). Described 
morphologic changes in the early pneumonitic phase include degeneration of type I 
pneumocytes, ultrastructural changes to the lamellar bodies in type II pneumocytes, blebbing 
and vacuolation in endothelial cells and swelling of the basement membrane. Secondary 
changes, which characterize the so-called exudative phase of pneumonitis, consist of increased 
capillary permeability with subsequent leakage of serum proteins, edema of the interstitium, 
and in some cases increased number of alveolar macrophages and debris in the alveolar space 
(Morgan and Breit, 1995; Nakayama et al., 1996). 
Manifested radiation pneumonitis does not always represent a premise for the development of 
radiation fibrosis, the delayed reaction that occurs 6 to 12 months after the completion of 
radiotherapy with similar clinical symptoms described for radiation pneumonitis.  
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Main histopathological abnormalities during development of radiation fibrosis are the 
thickening of alveolar septa, further degeneration of type II pneumocytes, loss of capillaries, 
and collagen deposition (Morgan and Breit, 1995; Nakayama et al., 1996).  
 
The direct toxic effect of IR to the lung tissue is due to DNA damage and subsequent mitotic 
cell death, in addition to a local production of reactive oxygen species (ROS) in diverse 
resident cells. Most likely, radiation-induced direct toxicity involves alveolar epithelial cells 
(AEC) type I and II and microvascular structures. The series of pathologic events occurring 
after irradiation continues with the so-called latent period, during which release of cytokines 
and chemokines from the affected cells and a direct or indirect activation of parenchymal and 
immune cells is taking place (Fleckenstein et al., 2007a; Rubin et al., 1995). Lung injury is only 
appreciable after this phase with exudative and inflammatory reactions, and it reflects the 
specific turnover time of the affected cell populations. A subsequent cascade of molecular 
events presumably induces migration of inflammatory cells, alteration of the tissue 
microenvironment, chronic lung inflammation, cell proliferation, tissue destruction, and repair 
to re-establish normal lung architecture and functions.  
 
In summary, lung damage following irradiation exerts an inflammatory response and activates 
the wound-healing machinery to re-establish tissue homeostasis. Such repair processes, as well 
as inflammatory reactions, if not properly regulated, can result in an inappropriate tissue 
regeneration leading to organ failure and death (Fig. 1.1) (Bentzen, 2006; Wynn, 2008).  
 
Although several molecular factors that contribute to fibrosis development have been identified 
(e.g. platelet-derived growth factor (PDGF), transforming growth factor-β (TGF-β)) (Thornton 
et al., 1996; Yi et al., 1996), the molecular and cellular events that link direct tissue damage to 
chronic inflammation and that regulate and promote delayed tissue remodelling and lung 
fibrosis are not completely understood. Moreover, it is still matter of debate whether the 
pathological repair process initiated by radiation-induced pneumonitis is a prerequisite for 
fibrosis development. 
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Fig. 1.1 Normal wound healing vs radiation induced fibrosis. Schematic overview of the well orchestrated 
wound healing machinery (above the timeline) activated in response to tissue injury, in comparison to the altered 
radiation-induced responses (below the timeline) which fail to re-establish tissue homeostasis (ECM = 
extracellular matrix; ROS = reactive oxygen species; RNS = reactive nitrogen species; TGFβ = transforming 
growth factor-β) (Bentzen, 2006). 
 
 
1.2 Prevention and therapeutic approaches  
 
The first approach to reduce radiation pneumonitis and fibrosis in cancer patients is a patient- 
specific radiation treatment schedule, aiming at limiting radiation doses and volumes. In 
addition, several pharmacological approaches have been used to reduce early and late side 
effects of radiation on lung tissue. Some of these will be listed. 
Corticosteroids have been used to treat radiation pneumonitis. In mice, they have been shown 
to markedly improve survival and physiologic abnormalities. In some reports, though with no 
preventive effects, the administration of corticosteroids as clinical pneumonitis occurred in 
cancer patients have shown amelioration of the inflammation. However, steroid therapy had no 
effect on the late pulmonary fibrosis (Abid et al., 2001). 
Amifostine is a cytoprotective compound in that it functions as a free-radical scavenger, and is 
under continued investigation in a number of clinical trials. Despite some reports described 
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amelioration of pneumonitis, others have shown no influence on the incidence of radiation 
pneumonitis (Bentzen, 2006; Tsoutsou and Koukourakis, 2006). 
The efficacy of antioxidant drugs has also been investigated. Use on animal models could show 
that angiotensin-converting enzyme (ACE) inhibitors or superoxide dismutase (SOD) 
analogues ameliorate both radiation pneumonitis and fibrosis, but clinical studies on the effects 
of these drugs in patients have not been reported so far (Graves et al., 2010). 
Recent studies showed significant protective effect for both early and late lung toxicity after 
prophylactic administration of the xanthine derivative pentoxifylline and vitamin E. Most of the 
patients obtained regression, and few the complete remission of fibrosis (Bentzen, 2006; 
Nakayama et al., 1996).  
A promising strategy to reduce radiation-associated fibrosis would be the inhibition of 
fibrogenic mediators, such as TGF-β. Pre-clinical studies already showed prevention or 
amelioration of radiation fibrogenesis and the targeting of TGF-β in rodent models reduced the 
severity or the risk of radiation-induced lung injury (Bentzen, 2006; Graves et al., 2010). 
Nevertheless, none of the mentioned approaches has been approved for treatment of 
radiation-induced pneumonitis and fibrosis. Therefore, a better understanding of the 
pathogenetic mechanisms of these lung disorders will help to identify critical regulators and to 
develop effective strategies for the prevention or treatment of radiation-induced pneumopathy.  
 
 
1.3 Models of radiation-induced pneumopathy 
 
The pathological processes of radiation-induced lung injury have been extensively investigated 
using several animal models including rats (Burger et al., 1998; Pauluhn et al., 2001), pigs 
(Rezvani et al., 1989), rabbits (Rubin et al., 1992) and mice (Down and Steel, 1983; Sharplin 
and Franko, 1989). However, here the murine model will be discussed in more details.  
Radiation induced-pneumonitis and fibrosis in mice are usually observed after a single 
exposure to hemithorax or whole thorax irradiation with 12-15 Gray (Gy) of dose. However, 
radiation effects are strain-dependent. Some strains show more severe or sub-acute pneumonitis 
and are fibrosis resistant, whereas others, such as C57BL/6 mice, have milder pneumonitis and 
are fibrosis prone (Franko et al., 1991; Moore and Hogaboam, 2008). Thus, C57BL/6 mice are 
the most widely used to investigate the pathogenesis of radiation-induced pneumopathy, with 
the additional advantage of the numerous genetic variants available.  
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Following thorax irradiation it has been shown that C57BL/6 mice display altered levels of 
cytokines, both within the lung tissue and in the bronchoalveolar lavage fluid (BALF) in 
comparison to sham irradiated mice (controls). An early increase of interleukin (IL)-1 in the 
first 2 weeks post irradiation (p.i.) was described and high levels of this cytokine, involved in 
macrophage and T cell recruitment, were noted at later time points up to 26 weeks p.i. In the 
same study, the two pro-fibrotic mediators TGF-β and PDGF showed an early reduction (week 
1), followed by a gradual increase and a peak at week 8. Control levels were reached again and 
a further increase was noted during the fibrotic phase, at 26 weeks p.i. (Rubin et al., 1995). 
Another study showed in addition increased levels of tumor necrosis factor alpha (TNF-α), but 
only in the first 2 weeks p.i. (Chiang et al., 2005). Appreciable signs of radiation induced 
pneumonitis are usually observed starting at week 3-4 p.i., when lymphocytes, after an initial 
depletion, are gradually returning to control levels and further increase at later time points 
(Chiang et al., 2005). Fibrosis development is irreversible and usually occurs 24-30 weeks p.i., 
when excess of collagen and cellular infiltrates are also detected and fibrotic foci are observed 
mainly in the subpleural region (Haston and Travis, 1997). Details about macrophage and 
T cell response to radiation-induced lung damage will be discussed separately in paragraphs 
1.5.2 and 1.6.2, respectively.  
 
Many other animal models, with more or less clinical relevance, are currently used to 
investigate the mechanisms involved in fibrogenesis. They include bleomycin (BLM), silica 
fibers, or fluorescein isothiocyanate (FITC) treatments, as well as the use of transgenic mice 
(Moore and Hogaboam, 2008). The BLM model of lung fibrosis is extensively used in 
research, thus it will be shortly introduced. Bleomycin is an antibiotic isolated from 
Streptomyces verticillatus that has been firstly used in the clinic for its antineoplastic activity. 
However, its use was downsized because of pulmonary toxicity, a reflection of the low levels 
of inactivating enzyme in this tissue. Lung damage following BLM exposure is due to 
induction of DNA strand breaks and subsequent excess of ROS formation. These events result 
in signs of acute lung injury, inflammation, and subsequent fibrosis (Moore and Hogaboam, 
2008). Despite the many advantages that this model provides including the variety of routes of 
administration and the fast development of fibrosis, as seen for the irradiation model the effect 
of BLM in mice is strain-dependent, but fibrosis is a self-limited response (Moore and 
Hogaboam, 2008).  
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The BLM model, although reproducing many features of human pulmonary fibrosis, is a model 
of acute lung injury, therefore the irradiation model is preferred to elucidate the development of 
chronic fibrosis.  
Nevertheless, in the effort to understand the mechanisms linking chronic inflammation and 
fibrosis, the BLM model and the use of transgenic mice have helped in the identification of 
some important molecular and cellular mediators involved in the fibrogenic process. In 
particular, one such mediator is adenosine (Ado), a signalling nucleoside that plays an 
important role in lung physiology, inflammation and fibrosis. 
 
 
1.4 Adenosinergic/purinergic signalling and lung injury 
 
1.4.1 Adenosine and adenosinergic pathway 
 
The purine nucleoside adenosine is involved in many physiological and pathological events and 
is a critical regulator of inflammatory responses. In normal physiologic conditions, adenosine 
levels in the extracellular space are relatively low, but during inflammation, hypoxia, infection 
and other pathological situations, they can rapidly increase. This evolutionary well-preserved 
mechanism activated during immune reactions aims at protecting cells and tissues from 
excessive damage (Bours et al., 2006). Adenosine can be produced intracellularly from 
adenosine monophosphate (AMP) by cytosolic 5'-nucleotidase, and passively diffused or 
actively secreted in the pericellular space via equilibrative nucleoside transporters. 
Alternatively and particularly after injury, the main source of adenosine is the catabolic 
extracellular hydrolysis of precursor nucleotides, such as adenosine triphosphate (ATP), a 
potent danger signal commonly released during tissue damage and cellular stress. The 
sequential phosphohydrolysis of ATP or adenosine diphosphate (ADP) in AMP is catalyzed 
through the enzymatic activity of the membrane-bound ectoapyrase cluster of differentiation 
(CD) 39 (NTDPase1 - ectonucleoside triphosphate diphosphohydrolase-1). AMP can be further 
hydrolysed to adenosine by the rate-limiting ecto-5'-nucleotidase CD73 (NT5E) (Fig. 1.2). 
Extracellularly and intracellularly, adenosine can be metabolised and converted to inosine by 
the enzyme adenosine deaminase (ADA), or phosphorylated to generate AMP by adenosine 
kinase (AK) (Fredholm, 2007; Zimmermann, 2000). 
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Fig. 1.2 Schematic overview of the extracellular purine metabolism. The extracellular generation of adenosine 
relies on the enzymatic activity of the ectonucleotidases CD39 and CD73. These ecto-enzymes stepwise convert 
ATP in adenosine, which can bind to specific adenosine receptors (A1, A2A, A2B, A3) leading to differential 
regulation of intracellular cyclic AMP (cAMP) in the target cell. Alternatively, extracellular adenosine can be 
converted into inosine by the action of the enzyme adenosine deaminase (ADA) (EC= extracellular; 
IC= intracellular).  
 
 
Adenosine exerts anti- or pro-inflammatory actions mainly through its binding to four 
G-protein-coupled receptors, namely adenosine receptors A1, A2A, A2B and A3. These receptors 
are widely expressed on immune cells, but also on endothelial and epithelial cells. They differ 
in their binding affinity and in their downstream effects, with the Gi/o-coupled A1 and A3 
receptors inhibiting adenylyl cyclase, thereby decreasing intracellular cyclic AMP (cAMP) 
levels, and the Gs-coupled A2A and A2B receptors, activating adenylyl cyclase and protein 
kinase A, therefore increasing cAMP levels in the cell (Hasko et al., 2008). 
The ectonucleotidase CD73 belongs to the 5'-nucleotidases, a family of soluble and 
membrane-bound enzymes that catalyse the hydrolysis of 5'-nucleotides. CD73 is a 70-kDa 
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glycosyl phosphatidylinositol (GPI)-linked protein expressed on the cell surface of many cell 
types including endothelial cells, immune cells, epithelial cells and dendritic cells (DC). In 
humans, CD73 is expressed in approximately 30 % of peripheral blood T cells and 70 % of 
B cells, whereas monocytes and natural killer (NK) cells are negative for CD73 (Resta and 
Thompson, 1997). Differences in the tissue distribution and activity of this enzyme suggest a 
wide diversity of physiological activities that extend beyond its enzymatic properties. A role in 
tissue barrier function and cell adhesion has indeed been described (Airas et al., 1995; Koszalka 
et al., 2004; Lennon et al., 1998).  
 
Among all the physiological properties of this molecule, adenosine has mainly 
anti-inflammatory effects exerted on a plethora of immune cells, therefore representing a 
beneficial response during acute injury states. On the contrary, elevated levels of adenosine are 
promoting and exacerbating tissue injury, contributing to progression of chronic disease state, 
including fibrosis. For example, in asthmatic patients or in patients suffering from chronic 
obstructive pulmonary disease (COPD) increased levels of adenosine have been found, 
suggesting a cause-and-effect role of adenosine in these disorders. Altered levels of adenosine 
were associated with increase of CD73, reduction of ADA activity, as well as with upregulation 
of some Ado receptors (Driver et al., 1993; Fozard and Hannon, 1999; Huszar et al., 2002). 
These evidences lead to the hypothesis that CD73 could represent an essential mechanism in 
the regulation of adenosine extracellular levels. The role of CD73/Ado pathway in fibrosis 
development has been investigated and will be discussed in the next paragraph. 
 
1.4.2 Adenosinergic pathway and fibrosis 
 
As mentioned above (par. 1.3), several studies on chronic pulmonary diseases using mouse 
models of lung fibrosis described a detrimental or beneficial role of adenosine. The main 
findings will be discussed. 
The first evidence of an implication of adenosine in lung inflammation, airway remodeling and 
chronic pulmonary injury was provided by the use of mice deficient for ADA, the purine 
catabolic enzyme responsible for the breakdown of adenosine. These mice present markedly 
elevated levels of adenosine in many organs including the lung, and die by 3 weeks of age from 
lung inflammation and pulmonary insufficiency. No signs of lung damage and respiratory 
failure were observed when exogenous ADA enzyme therapy was administered to these mice 
from birth. Even more interestingly, mice treated after the establishment of the pulmonary 
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damage could restore lung adenosine to control levels, recover and survive (Blackburn et al., 
1998; Blackburn et al., 2000; Chunn et al., 2001). In following investigations, experiments on 
ADA deficient mice treated with high dose or low dose of exogenous ADA enzyme could 
confirm that chronic elevations in lung adenosine correlate with fibrosis development (Chunn 
et al., 2006; Chunn et al., 2005). Pro-fibrotic mediators, such as TGF-β, were found to be 
elevated exclusively in the lung tissue of mice at low dose regimen, and the same mediators 
could be significantly reduced when lowering levels of endogenous adenosine through the 
replacement of ADA treatment with the high dose regimen. Similarly, a decrease of tissue 
adenosine through ADA therapy was shown to be beneficial in a mouse model with specific 
lung overexpression of interleukin (IL)-13, a pluripotent T helper cell type 2 (TH2) cytokine 
implicated in the pathogenesis of asthma. These mice develop features of chronic lung disease 
and fibrosis resembling the ADA deficient phenotype, with adenosine accumulation and a 
decreased ADA activity in the lung (Blackburn et al., 2003). Other studies have been useful to 
identify in the ADA deficiency model the A1 and the A2B receptors as mediators of anti-
inflammatory/tissue protective and pro-fibrotic/tissue destructive effects of adenosine 
respectively (Sun et al., 2005; Sun et al., 2006). 
 
In contrast with the above mentioned studies, the use of the BLM model of lung fibrosis could 
demonstrate that elevations of adenosine through CD73 are not necessary for the development 
of pulmonary fibrosis. In details, lung tissue of BLM challenged mice displayed adenosine 
accumulation and this increased level correlated with elevations in CD73 enzymatic activity. 
On the contrary, the administration of BLM to CD73 deficient mice was not leading to 
adenosine accumulation in the lung. In addition, these mice showed no compensatory increase 
in activity of other nucleotidases. BLM challenge was also differentially altering inflammation 
in the lung of CD73 deficient mice, which showed marked increase of inflammatory foci within 
the tissue and a greater level of total cells recovered from the BALF in comparison to CD73 
proficient mice. Interestingly, loss of CD73 resulted in enhanced collagen production and 
deposition, in addition to enhanced expression of pro-inflammatory and pro-fibrotic mediators 
and a lower survival following BLM exposure. Moreover, the intranasal administration of 
exogenous nucleotidase could elevate lung adenosine levels and reduce inflammation and 
collagen deposition in mice challenged with BLM, in the absence or presence of endogenous 
CD73. In this report, the production of adenosine by CD73 emphasizes an 
anti-inflammatory/tissue-protective role of this nucleoside (Volmer et al., 2006). 
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In summary, these models pointed out a crucial role of key components of Ado metabolism and 
signalling in respect to chronic lung pathologies, showing how therapeutic strategies addressed 
to regulate Ado levels (e.g. ADA enzyme replacement therapy, A2B receptor inhibitors) could 
improve the outcome of pulmonary pathology. Albeit the strong association between increased 
levels of adenosine and progressive inflammation and fibrosis, mechanisms regulating 
adenosine formation after lung injury are still considerably unexplored. In this context the 
indication of a key role for CD73 in the control of adenosine production is highly 
comprehensible, as suggested also by Volmer et al.. However, up to date the role of 
CD73/adenosine in radiation-induced pneumonitis and fibrosis remains unknown.  
 
 
1.5 Macrophages and lung injury 
 
1.5.1 Characteristics of macrophages 
 
Macrophages are major players in the innate immune response and are considered as 
professional antigen-presenting cells (APCs) with the ability to initiate specific lymphocyte 
effector mechanisms. Macrophages derive from monocytic precursor cells originated in the 
bone marrow from a common myeloid progenitor. Circulating peripheral blood mononuclear 
cells (PBMCs) differentiate and acquire specialized functions when migrating in different 
anatomical locations. Tissue macrophage functions involve homeostatic clearance processes 
and remodeling and repair of tissues after inflammation (Gordon and Taylor, 2005). Different 
stimuli can rapidly trigger macrophage activation and secretion of a multitude of inflammatory 
mediators leading to their participation in a variety of immune responses. Due to their 
remarkable plasticity and depending on the stimuli and the microenvironment, activated 
macrophages show a broad spectrum of phenotypes that influence their role in the initiation and 
the resolution of inflammation. The simplest scenario conceives two major macrophage 
phenotypes. Classically activated (M1) macrophages are induced by exposure to T helper cell 
type 1 (TH1) cytokines and interferon-gamma (IFN-γ) and are considered as pro-inflammatory 
and cytotoxic. This phenotype is associated with massive production of nitric oxide (NO), ROS 
and pro-inflammatory cytokines involved in cytotoxicity and microbicidal activity, such as 
IL-1β, IL-6, IL-12 and TNF-α. In contrast, alternatively activated (M2) macrophages are 
induced by TH2 cytokines (IL-4 and/or IL-13) and are involved in phagocytosis of apoptotic 
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cells, tissue repair, wound healing and resolution of inflammation. M2 macrophages produce 
anti-inflammatory cytokines such as IL-10, TGF-β and IL-1R antagonist, express high levels of 
arginase-1 (Arg1) and inhibit the production of pro-inflammatory cytokines. Moreover, 
alternatively activated macrophages are characterized by an increase in extracellular matrix 
remodeling, being therefore involved in tissue repair and homeostasis more than in immune 
defense (Gordon and Taylor, 2005; Mosser, 2003; Mosser and Edwards, 2008). However, the 
classification into two polarized states oversimplifies the complex and dynamic functional 
activity of these cells, which are able to differentially modulate their responses inducing 
peculiar gene expression patterns, in addition to rapidly adapt to progressive changes in the 
microenvironment (Martinez et al., 2008; Stout et al., 2005; Stout and Suttles, 2004). A tight 
regulation of macrophage functions and their cytokine production, as well as a balanced 
activity of the diverse macrophage populations are needed to avoid dangerous consequences. It 
is widely accepted that an aberrant regulation of M1 macrophages can lead to host tissue 
destruction, whereas uncontrolled repair processes driven by M2 macrophages can have a role 
in fibrosis development (Lupher and Gallatin, 2006; Martin and Leibovich, 2005; Mosser and 
Edwards, 2008). 
 
 
1.5.2 Lung macrophages - radiation responses and adenosinergic pathway  
 
Lung macrophages primarily originate from circulating monocytes, although local proliferation 
of a self-renewing population has been also described (Bitterman et al., 1984; Tarling and 
Coggle, 1982). Macrophages represent the most abundant immune effector population in the 
lung and comprehend cells residing in the interstitium and cells on the alveolar wall, namely 
alveolar macrophages (AM). The natural AM turnover is very slow but it can be accelerated 
after acute lung inflammation via recruitment of monocytes, which replace the resident alveolar 
macrophage population (Maus et al., 2006). 
Compared with other tissue macrophages, AM constitute a peculiar population exhibiting 
unique properties including unusual phenotypic features, such as the expression of high levels 
of CD11c and low expression of CD11b (Lambrecht, 2006; Lohmann-Matthes et al., 1994). 
The highly exclusive lung microenvironment provides specific signals, among those the 
macrophage colony-stimulating factor (M-CSF), granulocyte-macrophage CSF (GM-CSF), as 
well as surfactant proteins, which influence the development, growth and survival of these cells 
(Akagawa et al., 1988; Chen et al., 1988; Laskin et al., 2001). 
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Alveolar macrophages constantly survey the pulmonary surface to maintain the sterility of 
alveolar surfaces and proper gas exchange. In homeostatic conditions, AM retain a quiescent 
state, in that they show production of small amounts of inflammatory cytokines and little 
phagocytic activity. Moreover, they have been shown to actively suppress DC and T cells in the 
lung through the release of IL-10 and TGF-β (Lambrecht, 2006). At the same time, AM are the 
main initiators of inflammatory responses as a consequence of lung injury, being rapidly able to 
respond to insults, infectious agents or dangerous particles.  
Modulation of macrophage responses, as previously mentioned, has a major role in determining 
the progress and the resolution of inflammatory reactions, in that excessive repair processes 
driven by M2 macrophages have been associated to fibrosis development. One regulator of 
macrophage polarization and effector functions is adenosine. Due to the anti-inflammatory 
effect and the ability to decrease expression of several pro-inflammatory mediators in 
macrophages such as ROS and NO production, Ado can prevent excessive classical 
macrophage activation (Hasko et al., 2007). Moreover, with its positive regulation on 
anti-inflammatory cytokines, such as IL-10, Ado has been suggested to contribute to the 
phenotype switching of macrophages during inflammatory responses, a mechanism involved in 
the resolution of inflammation (Bours et al., 2006). 
 
As described in par. 1.1 and par. 1.3, lung inflammatory cells, both resident and recruited, take 
part in the tissue response to irradiation possibly determining the progression of radiation 
pneumonitis to fibrosis development. Among those, macrophages are of particular interest. In 
response to thorax irradiation, an initial decrease in the numbers of macrophages within the 
BALF has been described (1 week p.i.). Despite their dose- and fractionation-dependent 
sensitivity, AM show an immediate production of inflammatory mediators such as TGF-β, 
IL-1, TNF-α or PDGF-β. Subsequent to the initial decrease, AM rapidly repopulate the lung 
tissue. Macrophage numbers return to control levels by week 2 p.i., and a significant but not 
dramatic increase is noted between 3 and 6 months p.i. (Chiang et al., 2005). Lung interstitial 
macrophages respond to irradiation differently, in that they are involved in delayed 
inflammatory responses.  
Radiation-induced changes in macrophages include an increase in size and the presence of 
multinuclei, mainly at 3 week p.i and then again at later time points (6 months p.i.) (Chiang et 
al., 2005; Hong et al., 2003). The increase in size is also dependent on lipid accumulation in 
these cells, in that both in the BALF and in the tissue, an early appearance of foamy lung 
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macrophages has been documented. These enlarged foamy macrophages reappear during the 
late phase, at 6 months p.i. (Cappuccini et al., 2011; Chiang et al., 2005; Gross and Balis, 1978; 
Hong et al., 2003). Despite its common occurrence after thoracic irradiation during the 
pneumonitic phase, in none of these studies a specific marker for these cells could be identified.  
As mentioned above, activated AM, through the immediate release of different cytokines and 
chemokines can regulate and/or recruit many other cell types at the site of injury (Coggle et al., 
1986; Hong et al., 2003; Morgan and Breit, 1995; Rubin et al., 1992). A radiation-dependent 
release of pro-fibrotic cytokines has been documented also using in vitro assays. Cultured 
alveolar macrophages isolated from BALF of patients just prior to thoracic irradiation, secreted 
PDGF-β in a dose- and time-dependant manner after in vitro irradiation. In addition, BALF 
macrophages isolated from the same patients 4-6 weeks after radiation treatment, showed the 
spontaneous production of TNF-α and PDGF-β (Thornton et al., 1996). In a rat model of thorax 
irradiation, AM actively produced TGF-β when irradiated in vitro and BALF AM isolated 1 
months after in vivo irradiation were able to stimulate fibroblast proliferation via TGF-β (Rubin 
et al., 1992).  
 
These studies highlighted the role of the alveolar macrophage population in early responses to 
irradiation. However, the role of macrophages in the pathogenic process linking initial tissue 
damage in response to whole thorax irradiation to chronic inflammation and fibrosis remains 
still largely unknown.  
 
 
1.6 T lymphocytes and lung injury 
 
1.6.1 Characteristic of T lymphocytes 
 
The T cell population plays a central role in humoral and cellular immune responses, and with 
B lymphocytes constitutes the adaptive immunity. T lymphocytes originate in the thymus, 
where T cell clones with a receptor (TCR) recognizing self major histocompatibility complex 
(MHC) antigens on stromal cells are positively selected and will later develop into effector 
cells. Mature T cells will then be able to recognize peptide antigen in peripheral lymphoid 
organs in a MHCI context (CD8
+
) or MHCII context (CD4
+
). On the contrary, T cell clones 
with higher affinity to self antigens will be negatively selected to avoid autoimmune reactions. 
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Naïve T cells, upon TCR recognition of the specific antigen and with appropriate co-
stimulatory signals, proliferate and differentiate into effector cells. Different subsets of T cells 
with distinct functions have been characterized. A short description of the main T cell 
subpopulations follows (2008). 
 
CD4
+
 naive T cells are mainly differentiating into TH1 and TH2 subsets, involved in the 
stimulation of innate cellular immunity, and contributing in the humoral response influencing 
B lymphocyte properties. The classification depends on the specific cytokines produced by 
these cells. TH1 cells are induced by IFN-γ and IL-12 and secrete IFN-γ and IL-2, whereas TH2 
differentiation is favored by IL-4 and these cells produce IL-4 and IL-5. As a consequence, 
each activated TH subtype produces signals to amplify the differentiation towards its specific 
subtype, to generate TH1 or TH2 driven immune responses. A third CD4
+
 T cell subset is the 
TH17 population, mostly involved in the recruitment of neutrophils to sites of infection. TH17 
cells are differentiated in the presence of IL-6 and TGF-β and characteristically secrete IL-17, 
but not IFN-γ or IL-4. The expansion and development of this subset rely on the presence of 
IL-23 (2008). 
CD4
+
 regulatory T cells (Treg) have also been described, with the main function of suppressing 
T cell activation in the periphery therefore preventing excessive immune responses and 
autoimmunity during acute immune reactions. This subset produces TGF-β and IL-10, 
inhibitory cytokines involved in the suppression of T cell proliferation and activation. There 
exist natural Treg cells (nTreg), committed to a regulatory differentiation in the thymus, and 
induced Treg cells (iTreg), that differentiate directly in the periphery depending on specific 
environmental conditions. Both subsets of nTreg and iTreg cells specifically express the 
transcription factor forkhead box P3 (Foxp3), which activates genes that mediate the 
suppressive phenotype and silences many effector T cell genes (Sakaguchi et al., 2008). 
CD8
+
 T cells, also named cytotoxic T cells (CTLs), actively recognize and kill infected cells 
inducing apoptosis via direct membrane-binding or through release of cytotoxic granules 
containing granzymes and perforin. Costimulatory signals for CD8
+
 T cell activation are 
provided by APCs, such as DC, or by CD4
+
 TH cells (2008). 
The extinction of T cell immune responses after removal of the inflammatory threat consists in 
the apoptotic death of most of the activated cells, whereas only few will become long-lived 
memory cells (Bours et al., 2006).  
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1.6.2 Lymphocytes - radiation responses and adenosinergic pathway 
 
Generally, it is suggested that a shift from a TH1 to a TH2 response is likely to play an 
important role in the progression of inflammation to fibrosis. A dysregulation in the 
equilibrium of anti-fibrotic TH1-associated cytokines and pro-fibrotic TH2-associated cytokines 
could contribute to fibrogenesis (Thannickal et al., 2004; Wynn, 2008). Pro-fibrotic effects of 
Treg cells have also been postulated. In the attempt to dampen inflammation, these cells produce 
TGF-β and therefore may contribute to fibrosis (Luzina et al., 2008). Moreover, Treg cells have 
been shown to promote the activation of macrophages towards an M2 polarization state 
(Tiemessen et al., 2007).  
In general, CD73 is recognized as a maturation marker in lymphocytes due to its 
developmentally regulated expression, and has also been identified as a signal transducing 
molecule. In T lymphocytes, the binding of specific antibodies to CD73 in combination with 
suboptimal T cell receptor engagement was shown to be potent co-stimulatory signal for T cell 
activation and proliferation. Unfortunately, neither a specific interaction partner, nor 
mechanisms mediating CD73 effects have been clarified, though the GPI anchor and the 
enzymatic activity of CD73 were not absolutely required for CD73-mediated signal 
transduction (Dianzani et al., 1993; Gutensohn et al., 1995; Massaia et al., 1990; Resta et al., 
1994; Thompson et al., 1989). Noteworthy, it has been relatively recently discovered that Treg 
cells co-express high levels of CD39 and CD73. It is now widely approved that extracellular 
Ado generation constitutes a potent additional suppressive mechanism of these cells. 
Interestingly, Ado engagement of the A2A receptor has been shown to promote the generation 
of iTreg cells (Zarek et al., 2008). 
 
Radiation pneumonitis is characterized by increased infiltration of immune cells in the lung 
tissue and T lymphocytes represent a significant part of these infiltrating cells. In rodent models 
of thorax irradiation, after an initial depletion lymphocyte numbers recovered by 3 weeks and 
further increased in a dose-dependent manner, persisting also at later time point during the 
fibrotic phase (Chiang et al., 2005; Johnston et al., 2004). A selective increase in the 
CD4
+ 
T cell subset was noted at 4 weeks p.i.. This cell population has been reported to express 
IL-4, indicative of a TH2 response, until later phases (Westermann et al., 1999). 
In regard to T cell radiation responses in humans, a phenomenon named lymphocytic alveolitis 
(alveolar lymphocytosis) has been described in breast and lung cancer patients receiving 
therapeutic radiation treatment. Cell counts performed on the BALF of these patients after 
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completion of radiotherapy showed an increased number of lymphocytes with a predominance 
of the CD4
+
 subset. This reaction has been described to correlate with the degree of clinical 
symptoms of radiation pneumonitis, therefore more pronounced in symptomatic patients in 
comparison to asymptomatic patients. Moreover, the increase of lymphocytes infiltration was 
not only confined to the field of irradiation (Cordier et al., 1984; Gibson et al., 1988; Martin et 
al., 1999; Nakayama et al., 1996; Roberts et al., 1993). T cell sensitivity to IR could also be 
used as a predictive parameter for late tissue injury. A low rate of apoptosis in CD4
+
 and 
CD8
+
 T cells isolated from blood of cancer patients before and after receiving radiotherapy 
directly correlated with late side effects. No association between apoptosis and early toxicity 
was found in this prospective study (Ozsahin et al., 2005).  
 
Conflicting data have been published in the attempt to clarify the role of T cells in the 
fibrogenesis of the lung. Moreover, these studies were carried out using animal models of acute 
fibrosis. A short overview of the main findings follows.  
Frequency and severity of alveolitis and fibrosis after intraperitoneal (i.p.) injection of the 
radiomimetic drug BLM in nude mice were shown to be comparable to BLM treated control 
mice (Szapiel et al., 1979). Some years later, Schrier et al. showed that athymic mice after a 
single intratracheal (i.t.) administration of BLM were partially protected against pneumonitis 
and fibrosis (Schrier et al., 1983). In line with this group, Piguet et al. showed that mice 
depleted of CD4
+
 and CD8
+
 T cells were prevented from fibrosis development after i.t. 
instillation of BLM (Piguet et al., 1989). In another report it was shown that, after i.t. 
inoculation of BLM, fibrosis development was abrogated in immunosuppressed mice, whereas 
severe combined immunodeficiency (SCID) mice showed no differences in their fibrotic 
response in comparison to control mice (Zhu et al., 1996). Helene et al., using different mouse 
strains and the respective SCID counterparts, could confirm that the initial induction of this 
disease can be lymphocyte independent, though a different kinetic of collagen deposition was 
noted in BLM sensitive mouse strains (Helene et al., 1999). The T cell independent induction 
of lung fibrosis was also confirmed using FITC i.t. instillation. CD4
+
 depleted recombination 
activating gene (RAG) knock out and SCID mice in this study where showing identical 
increase of lung collagen deposition when compared to immunocompetent control mice 
(Christensen et al., 1999). 
 
The most data available in the literature describe the role of T cells in fibrotic processes in 
general. The impact of whole thorax irradiation on the time-dependent polarisation and 
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function of T cells recruited to the lung tissue is still largely unknown. Moreover, it is still 
unclear whether T cells play a functional role in the pathogenesis initiated by whole thorax 
irradiation and in the progression to lung fibrosis. 
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1.7 Aim of the study 
 
Radiation-induced pneumopathy (pneumonitis and fibrosis) constitutes a severe and 
dose-limiting side effect of thorax and whole body irradiation. Acute tissue injury leads to an 
inflammatory response followed by chronic inflammation with or without fibrosis 
development. The current hypothesis proposes that acute tissue damage triggers a delayed 
inflammation (pneumonitis) as well as lung fibrosis, involving complex interactions of resident 
lung cells, fibroblasts, the extracellular matrix and the immune system. As observed for other 
fibrotic diseases, an impaired balance between inflammation and repair may be causative for 
extensive remodelling processes and finally fibrosis. However, despite many reports and 
studies, the underlying mechanisms leading to radiation-induced lung injury are still poorly 
understood. In particular, the primary target cells, the key soluble regulators and the network of 
signals involved in and regulating the sequence of pathophysiological events after irradiation 
have to be identified in the need of developing effective strategies for prevention or treatment 
of radiation-induced pneumopathy.  
From other disease models it is known that tissue damage triggers the release of adenosine 
from resident cells and that chronically elevated extracellular levels of this immunomodulatory 
purine nucleoside are associated to fibrosis development. Therefore, the first focus of the 
experimental study was to analyze the role of the ecto-enzyme CD73, responsible for the last 
step of extracellular adenosine generation, in radiation-induced pneumopathy.  
Moreover, it is still controversial whether inflammation is a prerequisite for progression to lung 
fibrosis. Thus, the second focus of the present work was to characterize the radiation-responses 
of the innate and adaptive immune systems, and to gain a better understanding of their putative 
role in driving radiation-induced lung reactions towards fibrosis development. 
Overall, aim of the project was to investigate the processes linking radiation-induced tissue 
damage to tissue inflammation and fibrosis, and to characterize local and systemic 
radiation-induced immune changes in a murine model in vivo, using a single dose (15 Gray) of 
whole thorax irradiation on C57BL/6 wild type mice, as well as on CD73
-/-
 and RAG-2
-/-
 mice 
on a C57BL/6 background. 
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2  Materials & Methods 
 
2.1 Equipment and materials 
 
The equipment and materials used in this study are listed in Tables 2.1 and 2.2 below. 
 
Table 2.1 Equipment 
 
Item        Manufacturer 
autoMACS®      MiltenyiBiot, Bergisch Gladbach, Germany 
Cell counter and analyzer CASY®   Innovatis AG, Reutlingen, Germany 
Centrifuge Jouan CR422     Thermo Scientific, Dreieich, Germany 
Cobalt-60 source Philips    Netherlands     
Cryostat CM1850 UV    Leica Microsystems, Wetzlar, Germany 
Embedding station Shandon Histocentre
TM
 2 Thermo Scientific, Dreieich, Germany 
Flow cytometers FACS Calibur
TM
,    Becton Dickinson, Heidelberg, Germany 
      BD
 
LSR II
TM
,  
      BD
 
LSRFortessa
TM
  
Fluorescence microscope Axio Observer Z1, Carl Zeiss, Jena, Germany 
ApoTome, fluorescence filters (#49  
DAPI, #38HE eGFP, #43 HE CY3) 
Incubator Heraeus Cytoperm 2   Thermo Scientific, Dreieich, Germany 
Incubator      Memmert, Kirchheim u. Teck, Germany 
Inverted light microscope DMIRB,   Leica Microsystems, Wetzlar, Germany  
 AxioCam HRc    Carl Zeiss, Jena, Germany 
Micro-plate shaker     Oehmen, Essen, Germany 
Microtome RM2235,     Leica, Wetzlar, Germany 
  water bath, flattening table 
Tissue arrayer MTABooster® OI     Alphelys, Plaisir, France 
Tissue processor Shandon Excelsior
TM
 ES  Thermo Scientific, Dreieich, Germany  
Water bath Julab5B     Oehmen, Essen, Germany 
Water bath       Köttermann, Uetze/Hänigsen, Germany 
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Table 2.2 Disposables and materials 
 
Item        Supplier 
96-well plates U-bottom Cellstar   Greiner bio-one, Frickenhausen, Germany 
Barrier pen hydrophobic    Dako, Glostrup, Denmark 
Cell culture dishes (6, 10 cm)    Sarstedt, Nümbrecht, Germany 
Cell strainers (70, 100 µm)    BD Falcon, Heidelberg, Germany 
Coverslips       Engelbrecht, Edermuende, Germany 
Disposable glass capillaries    Brand, Wertheim, Germany 
Disposable filters CellTrics (30, 50 µm)  Partec, Görlitz, Germany 
Disposable scalpels Mediware   Servoprax, Wesel, Germany    
Embedding cassettes RotiLab   Roth, Karlsruhe, Germany 
Micropipettes      Gilson, Middleton, USA 
Microscope slides     Engelbrecht, Edermuende, Germany 
Microscope slides Superfrost Plus   R. Langenbrinck, Teningen, Germany 
Needles BD Microlance
 
3 (21, 23, 27 G)  BD, Drogheda, Ireland 
Objective slides      Engelbrecht, Edermuende, Germany 
Pasteur pipettes (3 ml) Plastibrand   Sigma-Aldrich, Deisenhofen, Germany 
Pipet boy      Starlab, Hamburg, Germany  
Pipet tips (100, 200, 1000 μl)    Greiner bio-one, Frickenhausen, Germany 
Pipet tips Multi Kristall (0.5, 10 μl)   Roth, Karlsruhe, Germany 
Plastic pipettes (1, 2, 5, 10, 25 ml)   Sarstedt, Nümbrecht, Germany 
PP-tubes (1.3 ml)     Greiner bio-one, Frickenhausen, Germany 
Scale Kern 474     Kern&Sohn, Balingen-Frommern, Germany 
Surgical tools      B Braun, Melsungen, Germany 
Syringes (1, 2 ml)      Terumo, Leuven, Belgium 
    (5 ml)     Dispomed, Gelnhausen, Germany 
    (10 ml)     Amefa, Limburg, Germany 
Tubes (0.5, 1.5, 2 ml)     Sarstedt, Nümbrecht, Germany 
Tubes (15, 50 ml)      Sarstedt, Nümbrecht, Germany 
Tubes round-bottom (5 ml)    BD Falcon, Heidelberg, Germany 
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2.2 Chemicals 
 
Chemicals, reagents and media used in this study are listed in Table 2.3 below. 
 
Table 2.3 Chemicals, reagents, media and kits 
 
Chemical/Reagent/Kit/Media   Manufacturer 
Acetic acid      Merck, Darmstadt, Germany 
Ammonium chloride (NH4Cl)   Merck, Darmstadt, Germany 
Bovine serum albumin (BSA)    Roth, Karlsruhe, Germany 
CD4
+
 T cell Isolation Kit    MiltenyiBiot, Bergisch Gladbach, Germany  
Cell culture media     Gibco, Karlsruhe, Germany 
  DMEM 
  RPMI 
Collagenase type V     Sigma-Aldrich, Deisenhofen, Germany 
Detection systems      Dako, Glostrup, Denmark 
 APAAP REAL
TM
, Mouse    
 DAB+ chromogen      
 DAB+ substrate buffer 
Eosin G      Roth, Karlsruhe, Germany 
Ethanol (EtOH)      Merck, Darmstadt, Germany 
Ethylenediaminetetraacetic acid (EDTA)  Roth, Karlsruhe, Germany 
Fetal calf serum (FCS)     Biochrom AG, Berlin, Germany 
Fluorescent mounting medium   Dako, Glostrup, Denmark 
Foxp3 Staining Buffer Set    eBiosciences, San Diego, USA 
Hank's balanced salt solution (HBSS)  PAA Laboratories, Cölbe, Germany 
Heparin-Natrium 25000    Ratiopharm, Ulm, Germany 
Hoechst 33258     Invitrogen, Karlsruhe, Germany 
Immersol      Carl Zeiss, Jena, Germany 
Isoflurane      Abbott, Wiesbaden, Germany 
Isopropanol       Sigma-Aldrich, Deisenhofen, Germany 
Masson-Goldner-Trichrome kit   Roth, Karlsruhe, Germany 
Mayer´s hematoxylin     Roth, Karlsruhe, Germany 
Mounting medium Roti Histokitt II   Roth, Karlsruhe, Germany 
Normal goat serum (NGS)    Sigma-Aldrich, Deisenhofen, Germany 
Octenisept      Schülke, Norderstedt, Germany 
Paraformaldehyde (PFA)     Merck, Darmstadt, Germany 
Phosphate buffered saline (PBS)    PAA Laboratories, Cölbe, Germany 
Pimonidazole HCl (solid)    Hypoxiprobe Inc, Barlington, USA 
Potassium bicarbonate (KHCO3)   Roth, Karlsruhe, Germany 
Sodium chloride (NaCl)     Merck, Darmstadt, Germany 
Sodium chloride 0.9 % (saline solution)  Fresenius Kabi, Bad Homburg, Germany 
Tissue-Tek® O.C.T.
TM
 Compound   Sakura Finetek, Torrance, USA 
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Chemical/Reagent/Kit/Media   Manufacturer 
Tris-base      Roth, Karlsruhe, Germany 
Triton X 100       Roth, Karlsruhe, Germany 
Xylene      Applichem, Darmstadt, Germany 
 
 
2.3 Buffers and solutions 
 
All solutions and buffers (unless otherwise noted) were prepared using double distilled water 
(ddH2O) (Table 2.4). 
 
Table 2.4 Buffers and solutions 
 
Name       Composition 
Ammonium chloride potassium buffer (ACK) 150 mM NH4Cl 
       10 mM KHCO3  
       0.1 mM EDTA 
 
Antibodies solution      - TBS, 1.5 % BSA 
       - PBS, 2% NGS 
       - PBS, 2% BSA 
Blocking solutions      - TBS, 5% BSA 
       - PBS, 2 % NGS 
 
Citrate buffer, pH 6.0     10 mM sodium citrate 
 
Collagenase solution      HBSS 
       2 mg/ml collagenase 
 
Complete media     DMEM/RPMI 
       10 % FCS   
 
FACS buffer       PBS 
       0.5 % FCS 
       2 mM EDTA 
 
FcR block solution      FACS buffer 
       anti-CD16/32 1:200 
 
Formalin 1 % solution    PBS 
       1 % PFA 
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Name       Composition 
Formalin 4 % buffered solution, pH 7.2  PBS 
       4 % PFA 
 
Permeabilization solution    PBS 
       0.1 % Triton 
 
Quenching solution      PBS 
       50 mM NH4Cl 
 
TBS        150 mM NaCl 
       10 mM Tris-base 
 
 
2.4 Antibodies 
 
Antibodies used in flow cytometry, immunohistochemistry and immunofluorescence are listed 
in Table 2.5. The combination of antibodies used in flow cytometric stainings of lung, spleen, 
blood and lymph nodes cells are listed in Table 2.6. 
 
Table 2.5 Antibodies 
 
Antibody Conjugate Clone Provider 
Actin, smooth muscle  ASM-1 Millipore 
Arginase 1  19 BD Biosciences 
CD3ε APC 145-2C11 eBiosciences/BioLegend 
 FITC 145-2C11 BD Biosciences 
CD4 APC RM4-5 eBiosciences 
 FITC GK1.5 / RM4-5 eBiosciences 
 PE RM4-5 BioLegend 
CD8 APC 53-6.7 eBiosciences 
 FITC 53-6.7 BD Biosciences 
CD11b FITC M1/70 eBiosciences 
 PerCP-Cy5.5 M1/70 BioLegend 
CD11c APC N418 BioLegend 
 PE N418 eBiosciences 
 PerCP-Cy5.5 N418 BioLegend/eBiosciences 
CD16/CD32  93 eBiosciences 
CD25 APC PC61 BD Biosciences 
 PE PC61.5 eBiosciences 
Materials and Methods 2 
 
 | 30  
 
Antibody Conjugate Clone Provider 
CD36 PE HM36 BioLegend 
CD39 PE-Cy7 24DMS1 eBiosciences 
CD45 eFluor 450 30-F11 eBiosciences 
CD45 Pacific Blue 30-F11 BioLegend 
CD45R/B220 FITC RA3-6B2 BioLegend 
 PE RA3-6B2 BioLegend 
 PerCP-Cy5.5 RA3-6B2 eBiosciences 
CD73 PE TY/11.8 BioLegend/eBiosciences 
 PE-Cy7 TY/11.8 eBiosciences 
CD115 (CSF-1R) PE AFS98 eBiosciences 
CD206 (MMR) PE CO68C2 BioLegend 
F4/80  CI:A3-1 AbD Serotec 
 APC BM8 eBiosciences 
F4/80 PE BM8 eBiosciences 
 PE-Cy7 BM8 BioLegend/eBiosciences 
Foxp3 APC FJK-16s eBiosciences 
 PE FJK-16s eBiosciences 
IgG Cy 2  Jackson Immuno Research Labs 
 Cy
 
3  Jackson Immuno Research Labs 
IgG HRP  Cell signaling/NEB 
IgG isotype control PE eBR2a eBiosciences 
IL-10 Rα  polyclonal R&D Systems 
Ly-6G and Ly-6C (Gr-1) FITC RB6-8C5 BD Biosciences/eBiosciences 
MAb1 (hypoxia)   Hypoxyprobe 
MHC Class II APC M5/114.15.2 eBiosciences 
NOS2 (iNOS)  C-11 Santa Cruz Biotechnology 
TGF-β1,2,3  1D11 R&D Systems 
 
 
Table 2.6 FACS stainings 
 
Antibodies combination     Tissue 
CD45*, CD8, CD4, CD39, CD3     Lung, spleen, lymph nodes 
CD45*, CD8, CD4, CD73, CD3     Lung, spleen, lymph nodes 
CD45, Gr1, B220        Lung 
CD45, CSF1R, F4/80, CD11c     Lung 
CD45, CD36, F4/80, CD11c      Lung 
CD45, MMR, F4/80, CD11c, MHCII    Lung 
CD45, F4/80, CD39, CD11c      Lung 
CD45, F4/80, CD73, CD11c      Lung  
CD45*, CD4, Foxp3, CD25      Lung, spleen, blood, lymph nodes 
*antibody used only for lung tissue 
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2.5 Softwares 
 
Alphelys-TMA Designer® (version 1.6.8) 
AxioVision (version 4.8) 
BD CellQuest
TM
 Pro (version 4.0.2) 
BD FACSDiva
TM
 software (version 5.0.2) 
FlowJo (version 7.6.5) 
GraphPad PRISM® (version 5.01) 
ImageJ (version 1.47c) 
 
 
2.6 Mice 
 
All mice were bred in the central animal facility of the University Hospital Essen. The origins 
of the parental breeding pairs are listed in Table 2.7. Mice were housed in individually 
ventilated cages (IVC) at a room temperature of 20-22 °C with a 12 hours light/dark cycle. 
Food and drinking water were provided ad libitum.  
All protocols for the animal experiments were approved by the University of Duisburg-Essen 
animal protection board in conjunction with the Landesamt für Natur, Umwelt und 
Verbraucherschutz Nordrhein-Westfalen (G 1094/09). Eight-to-twelve weeks-old males and 
females were enrolled in the study.  
 
Table 2.7 Mouse strains 
 
C57BL/6 wild type       Charles River, Sulzfeld, Germany 
CD73
-/-
 (C57BL/6 background)    Thompson et al., 2004  
RAG-2
-/-
 (C57BL/6 background)    Shinkai et al., 1992 
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2.7 Methods 
 
2.7.1 Thorax irradiation 
 
Mice were anesthetized with 3-5 % isoflurane in oxygen and placed in holders to assure a 
correct position during irradiation. The setup for the lung irradiation, including distance from 
the source, dose and irradiation leakage, was performed by local radiation physicists. A field of 
irradiation of 1.5 cm in width was adjusted to the thoracic area using a laser positioning system. 
Four mice simultaneously received a single 15 Gray (Gy) dose of whole thorax irradiation 
using a Cobalt-60 source (dose rate 0.5 Gy/min) while anesthetized with 0.8 % isoflurane. 
Non-irradiated parts of the body were shielded with lead blocks (Fig 2.1). Mice were closely 
monitored until fully recovered from anaesthesia and housed following standard procedures. 
Appropriate control groups (sham irradiated) of littermate mice, matched according to age and 
weight, were anesthetized under identical conditions. At selected end time points of 3, 6, 12, 24 
and 30 weeks after irradiation, mice were euthanized by carbon dioxide (CO2) inhalation and 
blood, spleen, lymph nodes, and lung tissue were collected for further analysis (Fig 2.1).  
 
 
 
3 6 12 3024weeks
1.5 cm
 
Fig. 2.1 Mouse model of whole thorax irradiation - Experimental setup. The cobalt-60 source is shown (upper 
left). The highlighted field of irradiation (in red) is defined by lead blocks (white arrows). Mice, placed in holders, 
receive 15 Gy whole thorax irradiation while anesthetized with isoflurane (upper right). At the indicated points 
(lower timeline), irradiated and sham irradiated mice are sacrificed and blood, spleen, lymph nodes and lung tissue 
isolated for further analyses. 
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2.7.2 Pimonidazole hydrochloride injection for determination of tissue hypoxia  
 
For tissue hypoxia determination, pimonidazole hydrochloride solution in 0.9 % saline was 
administered intraperitoneally at 60 mg/kg 30 minutes (min) before euthanasia. This compound 
is reductively activated in hypoxic conditions and forms stable adducts with proteins, peptides 
and amino acids, which can be recognized by a specific antibody. At selected end time points, 
mice were euthanized by carbon dioxide (CO2) inhalation and lung tissue was collected for 
further histological analysis. 
 
 
2.7.3 Isolation of blood cells 
 
Mice were euthanized by CO2 inhalation and, after fur disinfection, blood was immediately 
collected via cardiac puncture inserting a 27 Gauge needle below the xiphoid cartilage (cranial 
approach), or alternatively, at a perpendicular angle to sternum (perpendicular approach). 
Approximately 0.7-0.8 ml of blood per mouse were collected in 1.5 ml tubes. To avoid clotting, 
200 µl of the collected blood were transferred in tubes containing 30 µl heparin and further 
processed for flow cytometric stainings.  
In alternative, mice were anesthetized with isoflurane and approximately 0.1 ml of venous 
blood was regularly collected from the retroorbital plexus. To avoid clotting, the collected 
blood was transferred in tubes containing 10 µl heparin and further processed for flow 
cytometric stainings.  
 
 
2.7.4 Isolation of splenocytes  
 
Mice were euthanized with CO2 inhalation and, after fur disinfection the skin was cut on the 
left side of the abdomen and peritoneum opened to collect the spleen. Isolated spleens were 
directly placed on 70 µm cell strainers in 60 mm Petri dishes and perfused with ice-cold ACK 
buffer (Table 2.4) to lyse red blood cells (RBCs). Cell suspensions were always kept on ice and 
then transferred in DMEM medium containing 10 % fetal calf serum (FCS) and centrifuged at 
1500 rpm for 6 min at 4 °C. Complete DMEM medium was used to re-suspend cell pellets and 
spleen cells were counted using CASY® cell counter. From each animal, 1*10
6
 total spleen 
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cells (TSCs) was plated in a 96 U-well plate and processed for flow cytometric staining. In 
alternative, TSCs from untreated mice were used for CD4
+
 T cell isolation. 
 
 
2.7.5 CD4+ T cell isolation, autoMACS® depletion and adoptive transfer 
 
Spleens isolated from healthy and untreated C57BL/6 wild type mice were used for isolation of 
CD4
+
 T lymphocytes, taking advantage of the CD4
+
 T Cell Isolation Kit, following 
manufacturer instructions. In brief, the splenocyte suspension was incubated with a cocktail of 
biotin-conjugated monoclonal antibodies, directed to all leukocytes, but CD4
+
 T cells. Anti-
biotin monoclonal antibodies conjugated to magnetic micro beads were then added to the cell 
suspension. In the next step, the autoMACS® separator was used to retain labelled cells in the 
MACS® columns magnetic field. The cell suspension was depleted of all non-CD4
+
 T cells and 
unlabelled CD4
+
 T cells were purified through this process of negative selection. Freshly 
purified cells were evaluated for purity and injected (5*10
6
 cells/mouse) in the tail vein of 
RAG-2
-/-
 mice 1 day after receiving irradiation.  
 
 
2.7.6  Isolation of lymph node cells 
 
Euthanized mice were restrained on their back on the operating board. A sagittal cut was 
performed from the lower abdomen to the salivary gland and cervical lymph nodes were 
collected in complete medium in 60 mm Petri dishes and placed on ice; in some experiments all 
lymph nodes from the same treatment group were pooled. Lymph node cells were released in 
the medium disrupting the connective tissue capsule with the help of 23 Gauge needles and 
collected in 15 ml tubes, then centrifuged at 1500 rpm for 6 min at 4 °C and counted using 
CASY® cell counter. From each animal, 1*10
6
 lymph node cells (LNCs) per antibodies 
staining was plated in a 96 U-well plate. 
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2.7.7 Isolation of lung cells 
 
Euthanized and restrained mice were dissected as mentioned before and peritoneum was cut to 
expose the thoracic cavity. After carefully cutting diaphragm and the excision of the rib cage, 
lungs were isolated and minced into small pieces on microscope glass slides using sterile 
surgical blades and then collected in a 2 mg/ml collagenase solution in Hank's balanced salt 
solution (HBSS) on ice. Enzymatic digestion of the tissue was performed in a water bath at 
37 °C for 45 min and the reaction was stopped by adding ethylenediaminetetraacetic acid 
(EDTA) to a final concentration of 5 mM. The digested tissue was then mashed through a 
70 µm cell strainer and, to reduce cell loss, the cell strainer was washed with phosphate 
buffered saline (PBS). After centrifugation of lung cells for 10 min at 1200 rpm, lysis of 
erythrocytes was obtained incubating the cell pellets with 2 ml of ice-cold ACK buffer for 
1-2 min and stopped by adding PBS. Lung cell suspensions were centrifuged again for 10 min 
at 1200 rpm and cells re-suspended in fluorescence-activated cell sorting (FACS) buffer (Table 
2.4), passed through a 30 or 50 µm cell strainer to remove residual debris aggregates and 
counted using CASY® cell counter. 
From each animal, 0.5*10
6
 or 1*10
6
 total lung cells (TLCs) were plated in a 96 U-well plate 
and flow cytometric staining was performed. 
 
 
2.7.8 Flow cytometry  
 
Flow cytometry is a widely used method applied in medical and biological research. Generally, 
the use of flow cytometry allows to measure physical or chemical properties of single cells or 
particles. Briefly, cell suspensions are conveyed as single cell stream through beams of light. 
Scattered light or fluorescence emission, if cells have been labelled with fluorochromes, are 
collected through a system of optical filters and detectors, processed and returned as electrical 
signals that can be graphically plotted.  
For flow cytometry staining, 0.5*10
6
 or 1*10
6
 isolated cells from the mentioned tissues were 
plated in a 96 U-well plate and centrifuged at 1200 rpm for 10 minutes at 4 °C. Supernatant 
was removed and cell pellets were loosened on a plate shaker; cells were then re-suspended in 
100 µl FACS buffer containing the appropriate dilutions of the desired antibodies (Table 2.6) 
and incubated for 12 minutes at 4 °C in the dark. In case of TLCs, the staining step was 
performed adding 50 µl of the antibody solutions on cells that were pre-incubated for at least 
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15 min on ice with 50 µl FACS buffer containing fragment crystallizable receptor (FcR) block 
(Table 2.4). Following a washing step with FACS buffer, cells were centrifuged and loosened 
as mentioned before, re-suspended in 100-150 µl FACS buffer and transferred in 1.3 ml tubes. 
Alternatively, when cells could not be analyzed immediately, all probes were fixed in 1 % 
paraformaldheyde (PFA) solution in PBS and stored at 4 °C until measurement.  
Intracellular staining for forkhead box p3 (Foxp3) was performed using Mouse Regulatory T 
Cell Staining Kit according to manufacturer's instructions. Briefly, after surface staining, cells 
were washed with FACS buffer, centrifuged, loosened after supernatant removal and incubated 
for at least 30 min with 100 µl of the fixation/permeabilization working solution at 4 °C in the 
dark. Cells were then washed one time with 1X permeabilization buffer, centrifuged and 
loosened on a plate shaker. Incubation with anti-Foxp3 antibody or isotype control was 
performed in 1X permeabilization buffer for 30 min in the dark at 4 °C. Staining was then 
rinsed using FACS buffer and the plate centrifuged, supernatant discarded and cells loosened, 
resuspended in 100-150 µl FACS buffer and transferred in tubes for flow cytometric 
measurement.  
Staining data from TSCs and LNCs probes were acquired using a BD FACSCalibur
TM
 flow 
cytometer and analysed using BD CellQuest
TM
 Pro. Total lung cell probes were measured in a 
BD LSRFortessa
TM
 or, alternatively, in a BD LSRII
TM
 analyzer and staining data analysed with 
BD FACSDiva
TM
 and FlowJo softwares. 
 
 
2.7.9 Isolation and preparation of lung tissue for paraffin sections and cryosections 
 
Euthanized and restrained mice were dissected as mentioned before and peritoneum was 
opened to expose the thoracic cavity. The inferior vena cava was cut and the hearth perfused 
through the right ventricle with 2-4 ml of sterile PBS to remove any residual blood from the 
pulmonary vasculature. Next, using a 21 Gauge needle lungs were intratracheally inflated with 
4 % (wt/vol) PFA in PBS, pH 7.2, placed in embedding cassettes and then fixed overnight in 
the same solution. Alternatively, for the inflation a 1:1 mixture of pre-warmed Tissue-Tek® 
O.C.T.™ Compound and PBS was used and lungs placed in O.C.T. embedding medium, pre-
cooled on dry ice and stored at -80 °C. 
For hematoxylin and eosin (H&E) staining, Masson's trichrome staining and 
immunohystochemistry, after dehydration in 70 % ethanol, PFA-fixed lungs were processed 
using automated standard procedures and subsequently embedded in paraffin. Five µm tissue 
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sections obtained with a Leica microtome were mounted on coated microscope slides. 
Seven µm cryosections mounted on superfrost Plus microscope slides were obtained using a 
Leica cryostat. 
 
 
2.7.10 Tissue microarray 
 
The generation of tissue microarrays (TMAs) allows the analysis of numerous samples of tissue 
on a single slide. Tissue microarrays were built from 48 paraffin embedded lung tissues 
isolated from C57BL/6 wild type (22) and CD73
-/-
 mice (26). In details, areas of interest were 
identified on H&E stained slides, and from each lung tissue paraffin block (donor block) two 
tissue cores were punched out using a needle 1 mm in diameter. The tissue cylinders were then 
placed into the recipient TMA paraffin block using MTA Booster
TM
 OI manual tissue arrayer. 
The distribution and position of the cores were determined in advance with the TMA 
Designer
TM
 software. Cores of C57BL/6 wild type and CD73
-/-
 mice were incorporated in two 
different tissue array blocks. Five µm tissue sections obtained with a Leica microtome were 
mounted on coated microscope slides. 
 
 
2.7.11 Hematoxylin and eosin staining of lung sections 
 
The most commonly used staining system in histology is the hematoxylin and eosin stain 
(H&E). The combination of these two dyes allows the easy identification of tissue structures 
and cells on histological sections. Hematein, the oxidative product of hematoxylin, is a natural 
dye and stains cell nuclei purplish blue; eosin is an acidic dye that stains cell cytoplasm 
proteins and connective tissue fibers in different shades of pink and red.  
H&E staining on lung paraffin sections or cryosections was performed as follows. Lung slices 
(only paraffin sections) were deparaffinized by incubation at 65 °C over night and two 
additional incubation steps of 5 min in xylene. Rehydration of lung sections was obtained via 
5 min incubations in graded ethanol solutions (100 %, 90 % and 70 % EtOH in bidest water) 
and bidest water (paraffin and cryosections). To assess morphological alterations, the slides 
were then stained in Mayer's hematoxylin for 5 minutes and rinsed in running tap water for 
5-10 min. After 3 min incubation in 0.5 % eosin G in water, the slides were rinsed with bidest 
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water and subsequently dehydrated in graded ethanol solutions (70 %, 90 % and 100 % EtOH 
in bidest water) and xylene. Glass cover slips were mounted using ROTH mounting medium. 
Light microscopy pictures were obtained using a Leica DMIRB microscope equipped with a 
Zeiss AxioCam HRc color camera and Axiovision software.  
Quantitative analysis of fibrotic areas in irradiated mice was performed on pictures of whole 
lung sections using ImageJ software. For each mouse, at least 3 different slides with a 
minimum distance of 250 µm in depth were analysed. 
 
 
2.7.12 Masson's trichrome staining of lung sections 
 
The trichrome stain is used to selectively identify connective tissue, muscle and collagen fibers 
in tissue sections, therefore is widely adopted to observe histological changes in all diseases 
characterized by alterations of the amount of collagen, such as fibrosis. Typically, the 
molecular size of the employed acid dyes differs and determines the selectivity of the tissue 
structures stained. For Masson's trichrome staining, all staining solutions were obtained from 
the Masson-Goldner-Trichrome staining kit from ROTH. After tissue deparaffination and 
rehydration, lung slides were stained for 5 min in a 1:1 solution of Weigert's hematoxylin 
components A and B, and subsequently rinsed under running tap water for 5-10 min. The slides 
were then stained with the solutions Goldner I (ponceau - acid fuchsin), Goldner II 
(phosphotungstic acid - orange G) and Goldner III (light green SF), alternating the staining 
steps with 30 seconds washes in 1 % acetic acid solution in ddH2O to remove the stain in 
excess. The incubation time in the mentioned staining solutions was always adjusted 
proportionately to the intensity of the staining. After the standard dehydration procedure, glass 
cover slips were mounted using ROTH mounting medium. Nuclei are visible in violet-black 
colour, cytoplasm and muscles in red, erythrocytes in orange, and connective tissue, including 
collagen, in green colour.  
 
 
2.7.13 Immunohistochemistry on lung sections 
 
Generally, the binding of an antibody to its specific epitope is a widely used reaction in many 
laboratory techniques, and immunohistochemistry is one of those. The specificity of this 
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reaction helps to localize and discriminate cells or tissues of interest on histological sections; 
this is achieved by the use of antibodies directly labelled or, more commonly, by the use of a 
secondary labelling method.  
Lung slides were prepared according to the instructions given in the H&E staining paragraph. 
After rehydration, antigen retrieval was performed incubating the tissue sections in 10 mM 
citrate buffer pH 6.0 in a water bath at 98 °C for 15 min. The slides were then left to cool down 
at room temperature for 20 min. Next, two washing steps of 5 min were carried out in bidest 
water and Tris-buffered saline (TBS), followed by a 45 min incubation in 5 % bovine serum 
albumin (BSA) blocking solution in TBS. The tissue sections were then circled with a 
hydrophobic barrier pen and incubated over night at 4 °C in a moisture chamber with the 
appropriate dilution in 1.5 % BSA/TBS of the antibody of interest (Table 2.5). To detect 
antibodies binding, the alkaline phosphatase-anti-alkaline phosphatase (APAAP) or 
3,3'-diaminobenzidine (DAB) detection methods were chosen. For each staining, control slides 
were incubated with isotype control, with no primary antibodies or with only secondary 
antibodies. Counterstain was obtained with 5 min incubation in Mayer's hematoxylin. Glass 
cover slips were mounted using fluorescent mounting medium. 
A minimum of 5 pictures per lung section was evaluated to obtain a quantitative analysis of 
positively stained areas using ImageJ software.  
 
 
2.7.14 Immunofluorescence on lung sections 
 
Immunofluorescent techniques are based on the same principle described in the previous 
paragraph. In immunofluorescence, the localization of an antibody bound to its specific antigen 
is recognized by the use of a fluorochrome. Five µm sections from lung tissue microarrays 
were deparaffinized according to the instructions given in par. 2.7.11 and antigen retrieval was 
performed as mentioned in par. 2.7.13. Tissue sections were then circled with a hydrophobic 
barrier pen and permeabilized for 5 min with 0.1 % Triton in PBS. Next, the slides were rinsed 
3 times with PBS for 1 min and quenched with 50 mM ammonium chloride in PBS for 15 min. 
A second round of washing steps in PBS was performed and unspecific binding sites were 
blocked for 1 hour in a 2 % normal goat serum (NGS) solution in PBS. Subsequently, the 
blocking solution was removed and the slides were incubated over night at 4 °C in a moisture 
chamber with the appropriate dilution in 2 % NGS/PBS of the antibodies of interest 
(Table 2.5). The antibody solution was then removed and 3 rinsing steps in PBS for 3 min were 
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performed. Incubation of lung sections in 2 % BSA/PBS containing the appropriate secondary 
antibodies, labelled with cyanine dyes Cy2 or Cy3, was carried out at room temperature for 1 h 
and 30 min. Slides were then washed 3 times for 3 min in PBS and cell nuclei stained for 
15 min with Hoechst (1:1000 in PBS) in the dark. At last, slides were rinsed in PBS (3 times 
for 3 min) and mounted with fluorescent mounting medium.  
Lung slides were imaged using an inverted Zeiss Cell Observer fluorescence microscope 
equipped with the respective filter sets, an apotome and an Axiocam MRm. Overlay was 
performed with AxioVision software. 
Quantification of positively stained macrophages was performed on at least 4 pictures per 
mouse and a minimum number of 2 mice per condition.  
 
 
2.7.15 Semithin sections and electron microscopy samples 
 
Lung tissue samples used to obtain semi thin sections and analysed in electron microscopic 
studies were provided by Dr Eldh (University Hospital Tübingen). Mice in this case received a 
single dose irradiation of 15 Gy on the right hemithorax. The samples were kindly processed 
and prepared in the Institute of Anatomy at the University Hospital Essen (Dr Jastrow). In 
brief, 0.5 µm semithin sections were cut on a Reichert-Jung Ultracut-E. After drying at 90 °C, 
rinsed sections were stained with toluidine blue 1 %, methylene blue 1 %, and Azur-II 1 % 
solution in water (pH 8.0) plus 1 % sodium tetraborate. Preparation of electron microscopy 
samples was realized as follows. Glutaraldehyde fixed tissue contrasted with osmium tetroxide 
(OsO4), uranylacetate and lead citrate was investigated on a Zeiss EM902 transmission electron 
microscope. Images were acquired on a MegaViewII slow-scan-CCD camera using 
ITEM 5.0 software. 
 
 
2.7.16 Statistical analysis 
 
Results were analysed and graphically represented using Graph Pad Prism software. If not 
otherwise stated, data are presented as mean values ± standard deviation (SD). Statistical 
differences were assessed using unpaired t-test or two-way analysis of variances (ANOVA), 
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with p values ≤0.05 considered as significant. P values of survival curves where calculated by 
the log-rank (Mantel-Cox) test. 
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3 Results 
 
3.1 Importance of adenosinergic signalling pathway for radiation-induced fibrosis 
 
As mentioned in the introduction, pneumonitis and lung fibrosis still represent dose limiting 
side effects in cancer patients undergoing radiation therapy. The importance of CD73 and 
adenosine in many lung injuries has been broadly investigated and chronic elevation of 
adenosine levels within the lung tissue has been shown to be directly correlated to the 
inflammatory insult and fibrosis development (Blackburn et al., 2000); moreover, many 
studies describe the importance of the adenosinergic pathway in mouse models of lung 
fibrosis (Blackburn et al., 2000; Chunn et al., 2005; Volmer et al., 2006). However, the role 
of CD73 and adenosine in radiation-induced pneumonitis and fibrosis has not been 
investigated so far. C57BL/6 mice are sensitive to radiation and, after an initial pneumonitic 
phase at 6-16 weeks post irradiation (p.i.), they develop lung fibrosis (5-6 months p.i.). The 
experimental design to investigate radiation-induced pneumopathy was adapted from 
previous studies (Chiang et al., 2005; Heinzelmann et al., 2006). In order to determine the 
contribution of CD73 to the development of pulmonary inflammation and fibrosis, C57BL/6 
wild type mice (WT) and CD73 deficient mice (CD73
-/-
) mice received 15 Gray (Gy) whole 
thorax irradiation, whereas sham irradiated animals were treated with isofluorane anaesthesia 
only (control mice). 
 
3.1.1 Radiation-induced changes in body weight and survival 
 
Subsequent to whole thorax irradiation and throughout the 30 weeks of study, the body 
weight of control and treated C57BL/6 wild type (WT) and CD73
-/-
 mice was monitored 
every week, as changes in weight are ordinarily associated to the general health condition of 
mice. In Fig. 3.1 A body weight changes are shown for each group as average of delta (Δ) 
values calculated for each mouse subtracting the respective weight measured at the beginning 
of the experiment. Up to week 8, Δ values from all groups had approximately similar 
increase. While control mice and irradiated CD73
-/-
 mice continuously gained in weight, 
irradiated WT mice had a slower increase in body weight reaching the maximum at week 22, 
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corresponding to a Δ value of 3.2 ± 1.6 grams (g). Thereafter this group of mice showed a 
slow reduction in body weight ending at a Δ value of 1.9 ± 1.6 g at 30 weeks. On the 
contrary, irradiated CD73
-/-
 mice showed a similar gain in weight as respective controls, with 
a final Δ value of 4.5 ± 2.7 g. Differences in Δ weight were highly significant when 
comparing irradiated WT mice to respective controls, as well as to irradiated CD73
-/-
 mice.  
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Fig. 3.1 Changes in body weight and survival in C57BL/6 wild type and CD73
-/- 
mice. Weights and survival 
of C57BL/6 wild type (WT) and CD73
-/-
 mice were monitored over time after 15 Gy whole thorax irradiation or 
sham irradiation (anaesthesia only). A) Changes in body weight are represented as mean delta values (Δ weight 
= weight at day X – weight at day 0). Significant differences were calculated using two-way ANOVA test 
(***,### p≤0.001). B) Kaplan-Meier survival curves showing survival in percentage of irradiated WT (n=23) 
and CD73
-/-
 mice (n=23) at indicated time points. The shown p value was calculated by the log-rank 
(Mantel-Cox) test. 
 
 
Some of the mice receiving irradiation did not survive until week 30, the chosen end time 
point of the study. Survival rates of irradiated WT and CD73
-/-
 mice are shown in the 
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Kaplan–Meier survival curve of Fig. 3.1 B. Few irradiated mice died in the first 10 weeks 
p.i., with calculated survival rates at this time point of 87.7 ± 7 % and 95.6 ± 4.2 %, 
respectively in WT and CD73
-/-
 mice. A second critical phase started at week 21 for WT mice 
and at week 23 for CD73
-/-
 irradiated mice. By the end of the experiment survival percentages 
decreased to 69.6 ± 9.6 % in irradiated WT mice and to 78.3 ± 10.4 % in irradiated CD73
-/-
mice. Log-rank test analysis showed no significant difference in the survival curves between 
the two groups. 
The significantly higher increase in Δ weight and the slightly better survival of CD73-/- mice 
in comparison with irradiated WT mice suggest a distinct response of the two strains to 
irradiation. Therefore, in the next step lung tissue was isolated in order to assess local 
radiation-induced changes. 
 
 
3.1.2 Histological changes of lung tissue in irradiated C57BL/6 wild type and CD73-/-
 
mice 
 
To estimate radiation-induced tissue damage, lungs were isolated from the different groups at 
the time points of 3, 6, 12, 24 and 30 weeks p.i. and were processed for histological staining. 
In figure Fig. 3.2 A, representative pictures of hematoxylin and eosin (H&E) staining of lung 
sections from C57BL/6 wild type (WT; upper panel) and CD73
-/-
 mice (lower panel) are 
shown. No marked sign of inflammation, neither a marked alteration of lung architecture 
were noticed in both strains during the early response to irradiation (up to week 12). At later 
time points, fibrotic foci formation was clearly detected at 30 weeks p.i. in WT mice, whereas 
mostly no fibrosis was appreciable in CD73
-/-
 mice. Collagen deposition was also monitored 
over time using Masson's trichrome staining of lung sections, as shown in Fig. 3.2 B (upper 
panel: WT mice; lower panel: CD73
-/-
 mice). Similar to the H&E staining, no obvious 
changes were detectable in WT and CD73
-/-
 mice during the early phase p.i.. In contrast, 
enhanced collagen production associated with fibrotic areas was observed in the irradiated 
WT group.  
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Fig. 3.2 Lung histological changes in C57BL/6 wild type and CD73
-/- 
mice. Lung tissues were obtained 3, 6, 
12, 24 and 30 weeks (w) after whole thorax irradiation with 15 Gy or 0 Gy and prepared for histological 
analysis. A) Representative light microscopy pictures of H&E stained lung sections (5 µm) from C57BL/6 wild 
type (WT - upper panel) and CD73
-/-
 mice (lower panel) at all time points investigated (magnification x100; 
scale bars: 100 μm). B) Representative light microscopy pictures of Masson-Goldner trichrome stained lung 
sections from WT (upper panel) and CD73
-/- 
mice (lower panel) investigated at indicated time points 
(magnification x100; scale bar: 100 μm). 
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In order to determine the degree of pulmonary fibrosis at 30 weeks p.i. in irradiated WT and 
CD73
-/-
 mice, at least 2 additional tissue sections per animal were collected in a distal area of 
the lung (>250 µm distance in depth), and the extent of fibrosis was quantified. At this 
purpose, the percentage of fibrotic areas and the number of fibrotic foci per mouse were 
calculated in both strains and compared. More than 60 % percent of WT animals deriving 
from 2 independent experiments showed fibrosis at 30 weeks (data not shown), with an 
average of 5.1 ± 5.7 % of fibrotic areas (median value equivalent to 4 %), whereas only 50 % 
of CD73
-/-
 mice showed minimal fibrosis development with less than 2 % of fibrotic tissue 
(median value equivalent to 0,7 %) (Fig. 3.3 A). The number of fibrotic foci in WT mice was 
more than 2-folds higher than in CD73
-/-
 mice, with an average of 7.2 ± 7.0 and 2.3 ± 3.8 
respectively. The scatter dot plot in Fig. 3.3 B shows the median values of fibrotic foci per 
lung, corresponding to 7 in WT mice and 0.8 in CD73
-/-
 mice. Although a clear trend to 
increased fibrosis in irradiated C57BL/6 wild type as compared to CD73
-/-
 mice was 
observed, the obtained values were not statistically different.  
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Fig. 3.3 Quantitative analysis of fibrosis in C57BL/6 wild type and CD73
-/- 
mice. Lung sections were 
obtained from C57BL/6 wild type (WT) and CD73
-/-
 mice 30 weeks after 15 Gy whole thorax irradiation, 
stained with H&E and analysed for the amount of fibrosis and the number of fibrotic foci. A) Quantification of 
fibrosis extent in mice 30 weeks p.i. expressed as percentage of lung area showing fibrosis. B) Quantification of 
fibrotic foci in mice 30 weeks p.i.. Data represent median values obtained in ≥3 sections per mouse. 
 
Several acute and chronic pulmonary disorders are characterized by a decreased lung tissue 
oxygenation. The progressive thickening of the alveolar septa leads to breathing difficulties, 
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disturbance of local blood supply, and eventually to the development of severe alveolar 
hypoxia (Tuder et al., 2007). To examine whether radiation-induced lung damage is also 
associated with tissue hypoxia, control and irradiated mice were intraperitoneally injected 
with a hypoxia-sensitive prodrug, pimonidazole hydrochloride, 30 min before euthanasia. 
Paraffin embedded lung sections of WT and CD73
-/- 
mice from the different time points were 
subjected to immunohistochemical staining using a monoclonal antibody (MAb1) 
recognizing the hypoxia-related adducts mentioned above. Fig. 3.4 A shows the 
quantification of tissue hypoxia over time in irradiated and control WT and CD73
-/-
 mice. 
Irradiated WT mice showed increasing hypoxia already 6 weeks p.i., reaching a first 
maximum at 12 weeks p.i.. Of note, a second increase in tissue hypoxia was observed from 
week 24 to week 30 in these mice, which displayed diffuse hypoxia mainly in the fibrotic 
areas (Fig. 3.4 B). In contrast, irradiated CD73
-/-
 mice failed to develop significant tissue 
hypoxia neither during the early pneumonitic phase, nor during the late fibrotic phase (Fig. 
3.4 A). Only minor hypoxic areas were detected in CD73
-/-
 mice at 24 weeks p.i., primarily in 
peribronchial regions and single cells (Fig. 3.4 B). Thus, after whole lung irradiation CD73
-/-
 
mice presented a delayed onset and a lower level of tissue hypoxia compared to WT mice. At 
all time points, C57BL/6 wild type and CD73
-/-
 sham irradiated mice showed no or rare 
positivity of single cells or tissue.  
During the process of fibrogenesis, the enhanced synthesis of extracellular matrix is mainly 
attributed to the presence of myofibroblasts, activated fibroblasts producing collagen and 
other extracellular matrix proteins. Myofibroblasts overexpress α-smooth muscle actin 
(α-SMA), the primary stress fiber component involved in their strong contractile force (Hinz 
et al., 2007). TGF-β1 is a key regulator of ECM and has been shown to play a key role in 
fibrotic diseases. In pulmonary fibrosis, this cytokine contributes to myofibroblast 
differentiation and proliferation and is thought to be mainly produced by alveolar 
macrophages (Wynn, 2008). To corroborate the development of fibrosis, the presence of 
α-SMA and TGF-β was histologically evaluated in tissue microarrays generated from 
paraffin-embedded tissue blocks of control and irradiated WT and CD73
-/-
 mice. 
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Fig. 3.4 Quantitative analysis of hypoxic areas in C57BL/6 wild type and CD73
-/- 
mice. Irradiated and 
control C57BL/6 wild type (WT) and CD73
-/-
 mice were injected with pimonidazole hydrochloride 30 min 
before sacrifice. Lung sections were obtained from tissue isolated after 3, 6, 12, 24 and 30 weeks and 
immunostained with the antibody reagent MAb1, which specifically recognizes hypoxic-related adducts. 
Quantification of positive staining was performed using ImageJ. A) Data represent relative mean values ± SD 
compared to respective sham irradiated mice. At least 5 pictures per mouse were evaluated for positive staining 
(≥2 mice per group). B) Representative light microscopy pictures of immunohistochemical staining for hypoxia 
of lung sections at 30 weeks p.i.. Positive staining is indicated (black arrows) (magnification x100; scale bar: 
100 μm).  
 
As expected from previous results and in relation to fibrosis development, irradiated 
C57BL/6 wild type mice displayed a greater tissue positivity for both fibrotic markers at 30 
weeks when compared to CD73
 
deficient mice (Fig. 3.5 A). Intriguingly, lung macrophages 
at this time point were highly positive for α-SMA and TGF-β in WT mice (Fig. 3.5 B). No 
significant alterations were observed in control and irradiated mice at earlier time points, 
when α-SMA showed normal distribution surrounding blood vessels and bronchial airways, 
and no or weak staining for TGF-β was noted (Fig. 3.5 A and data not shown). 
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 Fig. 3.5 Immunohistochemical staining of TGF-β and α-SMA in lung sections. Lungs isolated at 3, 6, 12, 
24 and 30 weeks from irradiated and control C57BL/6 wild type (WT) and CD73
-/-
 mice were embedded in 
paraffin and used for the generation of tissue microarrays. Sections of tissue microarrays were immunostained 
with monoclonal antibodies specific for TGF-β or α-SMA. A) Representative light microscopy pictures of 
immunohistochemical staining for TGF-β and α-SMA of lung tissues at week 30 p.i. (magnification x100; scale 
bar: 100 μm). B) Representative light microscopy pictures of positively stained macrophages (black arrows) in 
WT mice at 30 weeks p.i. (magnification x1000; scale bar: 10 μm). 
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3.1.3 Cellular changes of lung tissues in irradiated C57BL/6 wild type and CD73-/- 
mice 
 
As mentioned in the introduction (par. 1.1), not all the fibrotic processes develop as a 
consequence of inflammation and it is still matter of debate whether radiation pneumonitis 
and fibrosis should be seen as a continuum.  
Data from histological and immunohistochemical analyses suggested distinct tissue responses 
of irradiated C57BL/6 wild type and CD73
-/-
 mice to IR and, above all, a noteworthy 
difference in fibrosis development related to endogenous expression of CD73. The 
CD73/adenosine system plays an important physiological role in the maintenance of lung 
homeostasis and therefore has been implicated in several airways disorders such as lung 
fibrosis, but is also a key regulator of many inflammatory processes (Cronstein, 1994; 
Spicuzza et al., 2006). In order to analyse whether loss of CD73 would alter 
radiation-induced lung inflammation and/or immune cell functions thereby decreasing 
radiation-induced late lung injury, the effects of whole thorax irradiation on immune cell 
infiltration were followed over time. Lung tissues from control and irradiated C57BL/6 wild 
type and CD73
-/-
 mice were isolated at different time points, processed as described in 
par. 2.7.7, and evaluated by flow cytometry.  
At first, the distribution of total leukocytes in the lung was compared. The glycoprotein CD45 
is expressed at high levels on the cell surface of all nucleated hematopoietic cells and their 
precursors, and represents the leukocyte common antigen. Lung tissues isolated from control 
mice showed no variation in leukocytes content (CD45
+
 cells) at all time points analysed, 
with average values ranging from 31.4 ± 9.1 % to 39.6 ± 4.1 % of total lung cells in WT mice 
and from 33.5 ± 6.1 % to 40.8 ± 3.7 % in CD73
-/-
 mice (Fig. 3.6 A). In WT mice, whole 
thorax irradiation led to a significant increase of CD45
+
 cells at 6, 12 and 24 weeks post 
irradiation. Similarly, in CD73
-/-
 mice increased percentage of leukocytes was significant at 6, 
12 and 24 weeks post irradiation, but was stably higher than control values even at week 30. 
The comparison of the relative increase of CD45
+
 cells between WT and CD73
-/-
 mice 
pointed out a similar response to irradiation, with a peak of infiltration at week 12 p.i. 
(Fig. 3.6 A).  
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To gain insight into the contribution of specific immune cells to the inflammatory infiltrate, 
in a next step different sub-populations of infiltrating leukocytes were characterised. The 
gating strategy used for flow cytometric analysis of the different cell subsets is shown as dot 
plots in the corresponding figures.  
Flow cytometric analysis of lung tissue did not show a significant alteration of granulocyte 
infiltration (Gr1
+ 
cells) after irradiation in C57BL/6 wild type at all time points, while at 24 
and 30 weeks a tendency to a higher local presence of Gr1
+
 cells was noted in CD73
-/-
 mice, 
with relative percentages corresponding approximately to a 2-fold increase compared to 
control mice (Fig. 3.6 B). B lymphocytes have also been compared in control and irradiated 
mice, and a significant 1.3-fold increase was displayed by WT mice at 12 weeks p.i., 
expansion not observed in CD73
-/- 
mice (Fig. 3.6 C). Overall only subtle differences in the 
composition of the immune cell infiltrate were observed between lungs of irradiated WT and 
CD73
-/-
 mice at specific time points p.i..  
As mentioned in the introduction, IR is known to increase the number of leukocytes in the 
BALF of cancer patients, and in particular of T lymphocytes (par. 1.6.2), therefore it was 
particularly interesting to verify whether the mouse model could mirror such a common 
feature. In control mice, around 5 % of total lung cells were represented by CD3
+
 cells 
(Fig. 3.6 D) and whole thorax irradiation slightly reduced the percentage of T cells both in 
WT and CD73
-/-
 mice at week 3 p.i.. A significant T cell infiltration occurred in WT mice 
from week 6 until week 12, and the amount of infiltrating cells gradually decreased to control 
levels at later time points. Interestingly, in CD73
-/-
 mice the increase in T cells lasted longer, 
maintaining high levels until week 30. When comparing the two strains using percentages 
relative to respective control values, T lymphocytes of CD73
-/-
 mice showed higher resistance 
to radiation at the beginning of the inflammatory phase and a persistent lung infiltration 
(Fig. 3.6 D).  
Lung resident macrophages can be distinguished from the newly recruited macrophages by 
the expression of the marker CD11c. Therefore the gating strategy based on the coupled 
expression of F4/80 and CD11c allows the identification of these two cell populations 
(Fig. 3.6 E and F). 
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Fig. 3.6 Determination of leukocyte content in lung tissue by flow cytometry. C57BL/6 wild type (WT) and 
CD73
-/-
 mice received 0 Gy or 15 Gy whole thorax irradiation. At 3, 6, 12, 24 and 30 weeks p.i. lung tissue was 
used for cell isolation and flow cytometric analysis using antibody stainings for (A) total leukocytes (CD45
+
 
cells), (B) granulocytes (Gr1
+
 cells), (C) B lymphocytes (B220
+
 cells), (D) T lymphocytes (CD3
+
 cells), and 
alveolar (F4/80
+
CD11c
+
) or infiltrating (F4/80
+
) macrophages (E, F). Timelines of the indicated cell populations 
show mean percentages ± SD calculated on total lung cells (TLCs). To compare radiation effects in WT and 
CD73
-/-
 mice, mean values calculated in treated mice were normalized with respect to control values (lower 
left). For each cell population analysed, the respective gating strategy is shown as a dot plot (lower right). The 
number of mice used in the analyses is indicated within the bars (*= 0 Gy vs 15 Gy; #= WT vs CD73
-/-
)   
(*,# p≤0.05; **,## p≤0.01; *** p≤0.001; two-tailed unpaired t-test). 
 
In the early phase of inflammation alveolar macrophages, unlike other immune cells in the 
lung, showed a significant reduction of their percentages compared to sham irradiated 
animals in both mouse strains. This macrophage population restored to control levels at week 
6 p.i. and further increased peaking at week 24. Statistical analysis on relative percentages 
underlined a higher decrease of alveolar macrophages deriving from irradiated C57BL/6 wild 
type mice at week 3 p.i. in comparison to CD73
-/-
 mice, with an approximately 3-fold and 
2-fold decrease of this population in the lung, respectively. Both mouse strains displayed the 
same tendency to repopulate the tissue at later time points. With respect to infiltrating 
macrophages, whole thorax irradiation did not cause important changes at all time points 
investigated. Moreover, WT and CD73
-/-
 mice showed a similar trend in maintaining lung 
homeostasis of the macrophage compartment. 
 
3.1.4 Local and systemic adenosinergic pathway regulation in T lymphocytes  
 
Histological analysis of lung tissue suggested that the absence of CD73 leads to a better 
outcome of whole lung irradiation with respect to fibrosis development. However, radiation 
induced only subtle changes in the immune cell composition. Therefore, in a next step the 
question was addressed whether radiation affects immune cell functions by altering the 
expression and/or activity of the adenosinergic pathway. To this end, T cells in the lung were 
analysed for the expression of CD73 and CD39, the ectonucleotidase acting upstream of 
CD73 (par. 1.4.1). For a more immediate interpretation of the data, only relative values of 
irradiated WT and CD73
-/-
 mice compared to respective controls are shown (Fig. 3.7). In WT 
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mice a significant upregulation of CD39 on T cells was noted at late time points reaching 
maximum levels at week 30 p.i.. T cells in CD73
-/-
 mice, though maintaining high levels of 
CD39 throughout the whole experiment, never showed significant differences in relative 
percentages at any time after irradiation.  
 
*
CD39 on T cells
3 6 12 24 30
0
100
200
300
weeks
re
la
ti
v
e
 %
***
96 56 596 36 3
CD73 on T cells
3 6 12 24 30
0
100
200
weeks
re
la
ti
v
e
 %
**
96 56 5
50
150
CD73-/-WT
 
Fig. 3.7 Determination of CD39 and CD73 expression on lung T cells by flow cytometry. C57BL/6 wild 
type (WT) and CD73
-/-
 mice received 0 Gy or 15 Gy whole thorax irradiation. At 3, 6, 12, 24 and 30 weeks time 
points, lung tissue was used for cell isolation and antibody staining for T lymphocytes (CD3
+
 cells) in 
combination with anti-CD39 and anti-CD73 antibodies. To compare radiation effects in WT and CD73
-/-
 mice, 
timelines show mean values ± SD of CD39
+
 or CD73
+
 on CD3
+ 
cells in irradiated mice normalized with respect 
to control values. For each analysis, the number of mice used is indicated within the bars (*= 0 Gy vs 15 Gy) 
(* p≤0.05; ** p≤0.01; *** p≤0.001; two-tailed unpaired t-test). 
 
 
Whole lung irradiation also triggered upregulation of CD73 on T cells in WT mice. However, 
upregulation of CD73 was an early event, with a maximal upregulation of approximately 
1.5-folds at 3 weeks p.i., while at later time points no significant alteration of CD73 
expression on T cells could be observed.  
Altogether, these results revealed radiation-induced changes in the percentage of 
T lymphocytes, as well as an altered regulation of the adenosinergic pathway in response to 
whole lung irradiation.  
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Fig. 3.8 Determination of lung CD4
+
 and CD8
+
 T cells and their CD39 and CD73 expression by flow 
cytometry. C57BL/6 wild type (WT) and CD73
-/-
 mice received 0 Gy or 15 Gy whole thorax irradiation. At 3, 6 
and 12 weeks, lung tissue was used for cell isolation and flow cytometric measurement. (A) Relative 
percentages of CD4
+
 T lymphocytes in irradiated lungs and surface expression of CD39 and CD73. (B) Relative 
percentages of lung CD8
+
 population of irradiated mice in combination with anti-CD39 and anti-CD73 
antibodies. Timelines show mean values ± SD calculated in treated mice normalized with respect to control 
groups. Absolute percentages of CD4
+
 and CD8
+
 cells were calculated on TLCs. For each analysis, the number 
of mice used is indicated within the bars (*= 0 Gy vs 15 Gy; #= WT vs CD73
-/-) (* p≤0.05; ** p≤0.01; 
***,### p≤0.001; two-tailed unpaired t-test).  
 
 Results 3 
 
 | 59  
 
Because of the role of adenosine in many function of T cells involved in inflammatory 
processes and the early changes observed in CD73 expression, it was next analysed to what 
extent whole lung irradiation would affect specific T cell subsets in their expression of CD39 
and CD73, focusing on the pneumonitic phase.  
Similar to the results obtained in CD3
+
 T cells, at week 3 after whole thorax irradiation 
relative percentages of CD4
+
 T cells were significantly higher in CD73 deficient mice 
compared to C57BL/6 wild type mice. However, at later time points p.i. similar relative 
increases were found in WT and CD73
-/-
 mice (Fig. 3.8 A). In both strains, a trend in the 
upregulation of CD39 on CD4
+
 T cells was noted in the pneumonitic phase (weeks 3 to 12), 
especially in CD73
-/-
 mice. Although percentages of lung CD4
+
 T lymphocytes were largely 
decreased 3 weeks p.i. in WT mice, the remaining cells showed a significant upregulation of 
CD73 at this time point. CD73 expression reached the levels of controls at 6 and 12 weeks 
p.i., when the amount of CD4
+
 cells on total lung cells was approximately 1.6-fold higher 
compared to sham irradiated mice (Fig. 3.8 A).  
An analogous response to thorax irradiation was observed in the CD8
+
 T cell population. In 
WT mice, a more prominent decrease in relative percentages was measured at 3 weeks p.i. as 
compared to CD73
-/-
 mice, and at later time points both strains showed comparable increases 
of the CD8
+
 T cell subset. Only minor or no radiation-induced effects were noted on the 
regulation of the CD39 and CD73 in this cell population (Fig. 3.8 B). 
 
Radiation mainly affected percentages and CD39/CD73 surface expression of the 
CD4
+
 T cell subset in the lung. In order to understand whether radiation could influence 
immune cells in the periphery, the systemic response was next investigated. At this purpose, 
lymphocytes isolated from spleen and cervical lymph nodes were also included in the study 
and results are shown in Fig. 3.9. Similarly to what was observed in the lung, radiation 
caused a significant reduction in the percentages of CD4
+
 T cells in WT and CD73
-/-
 mice at 
3 weeks p.i., both in the spleen and lymph nodes, and control levels were restored at later 
time points. In the spleen, the decrease of CD4
+
 T cells was accompanied by a 5 % increase 
in the expression of CD39 in both mouse strains (Fig. 3.9 A). In lymph node cells the 
upregulation of this enzyme was also observed, but to a lesser extent (Fig. 3.9 B). As already 
described for the lung tissue of WT mice, radiation significantly induced CD73 expression on 
CD4
+
 T cells at week 3 p.i. in splenocytes and lymph nodes cells.  
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These data suggest that the systemic T cell response at least partially mimics the local T cell 
radiation-induced changes observed in the lung. 
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Fig. 3.9 Determination of spleen and lymph nodes CD4
+
 T cells and their CD39 and CD73 expression by 
flow cytometry. C57BL/6 wild type (WT) and CD73
-/-
 mice received 0 Gy or 15 Gy whole thorax irradiation. 
At 3, 6 and 12 weeks time points, spleen and lymph nodes were isolated and cells stained for flow cytometric 
analysis. (A) Percentages of spleen CD4
+
 T lymphocytes on total spleen cells (TSCs) and surface expression of 
CD39 and CD73. (B) Percentages of CD4
+
 T lymphocytes population in cervical lymph nodes (LN) in 
combination with anti-CD39 and anti-CD73 antibodies. Data represent mean percentages ± SD (n≥3 or pooled 
cells from n≥3; * p≤0.05; ** p≤0.01; *** p≤0.001; two-tailed unpaired t-test).  
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3.1.5 Local and systemic analysis of regulatory T cells in the pneumonitic phase 
 
Regulatory T cells (Treg) have been shown to co-express on their surface CD39 and CD73 and 
production of adenosine mediated by these two ecto-enzymes has been described as one of 
the mechanisms in the suppressive machinery of Treg cells used to control immune responses 
(Deaglio et al., 2007; Kobie et al., 2006). Although earlier investigations in humans and 
rodents already showed infiltration of CD4
+
 (and CD8
+
) T cells into irradiated lungs, up to 
now the potential role of Treg cells in the immune response of irradiated normal tissues, 
including the lung, is largely unexplored (par. 1.3 and 1.6.2). Therefore, it was of interest to 
investigate whether the early increase in CD39 and CD73 on CD4
+
 T cells observed in 
response to radiation was due to an expansion of regulatory T cells, both locally and 
systematically. As shown in Fig. 3.10, in the irradiated lung tissue, CD4
+
CD25
+
Foxp3
+
 Treg 
cells slightly increased in CD73
-/-
 mice compared to untreated control at 3 weeks, while a 
significant and higher than 4-fold expansion of these cells was detected in WT mice. 
 
Foxp3+
3 6 12
0
100
200
300
400
500
600
700
#
WT
CD73-/-
**
weeks
C
D
4
+
c
e
ll
s
re
la
ti
v
e
 %
A B
CD25
F
o
x
p
3
0 Gy 15 Gy
4.1 % 18.0 %
46 4 46 4
 
Fig. 3.10 Determination of lung Treg cells by flow cytometry. C57BL/6 wild type (WT) and CD73
-/-
 mice 
received 0 Gy or 15 Gy whole thorax irradiation. At 3, 6 and 12 weeks p.i., lung tissue was used for cell 
isolation and flow cytometric measurement. (A) Timeline shows percentages ± SD of CD4
+
CD25
+
Foxp3
+
 
T lymphocytes population in irradiated lungs relatively to percentages of control mice. The number of mice used 
is indicated within the bars (*= 0 Gy vs 15 Gy; #= WT vs CD73
-/-) (# p≤0.05; ** p≤0.01; two-tailed unpaired 
t-test). (B) Representative dot plot showing the increase in Foxp3
+
CD25
+
 cells from the CD4
+
 population 
detected in WT mice at week 3.  
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However, the increase in the Treg cell population was only transient and was no longer 
observed at 6 and 12 weeks p.i.. Similar results were obtained in the spleen and cervical 
lymph nodes of WT mice (Fig. 3.11). Of note, WT mice showed a biphasic increase in 
Treg cells in the irradiated lung tissue (Supplementary data, Fig. 7.1). Unfortunately, the data 
for CD4
+
 and Treg cells are missing in the CD73
-/-
 mice because of experimental difficulties.  
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Fig. 3.11 Determination of systemic Treg cells by flow cytometry. C57BL/6 wild type (WT) and CD73
-/-
 mice 
received 0 Gy or 15 Gy whole thorax irradiation. Lymphocytes were isolated from the spleen and cervical 
lymph nodes (LN) at 3, 6 and 12 weeks p.i., and used for flow cytometric measurement of T reg cells. Timelines 
show absolute percentages ± SD of CD4
+
CD25
+
Foxp3
+
 T lymphocytes population in the mentioned tissues of 
WT and CD73
-/-
 mice (* p≤0.05; ** p≤0.01; two-tailed unpaired t-test). 
 
A slightly different response to radiation was found in spleen and lymph nodes of CD73
-/- 
mice. Following an almost 2-fold increase measured at 3 weeks, irradiated mice seemed to 
maintain throughout the pneumonitic phase slightly higher levels of Treg cells in these tissues 
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in respect to control mice. These data show that the systemic response at least partially 
mimics the local response of the immune system.  
Altogether, results obtained indicated that whole thorax irradiation triggers time-dependent 
local and systemic activation of the adaptive immune system, and that the main differences 
between WT and CD73
-/-
 mice can be found primarily in the activation of specific T cell 
subset and in the modulation of the surface expression of the adenosinergic pathway 
members, rather than in quantitative effects induced by radiation.  
 
3.1.6 Macrophage characterization 
 
3.1.6.1 Histological analysis of macrophages - morphology and phenotype 
 
The CD73/Ado system is not only of importance for the regulation of immunosuppressive 
functions of lymphocytes, but also contributes in the regulation of macrophage functions 
(Hasko et al., 2007; Linden, 2006).  
Alveolar macrophages represent the first line of defence in the lung and they are rapidly 
involved in the initiation of immune responses whenever an inflammatory stimulus occurs 
locally. In addition, their extraordinary plasticity allows them to play also a central role in the 
modulation and resolution of inflammation (Stout et al., 2005). As a consequence, it was 
interesting to examine the quantitative reaction of macrophages to radiation-induced lung 
injury, as well as the potential of IR to affect their activation/polarization state. Moreover, 
because of the role of CD73 and adenosine in the regulation of macrophage activation and 
function, it was important to evaluate potential differences between the response of the 
macrophage compartment in WT and CD73
-/-
 mice that may also be of relevance for the 
outcome of radiation-induced pneumopathy. 
In a first step, semithin sections and electron microscopy samples of lung tissue from 
irradiated and control mice were analysed, and constituted a powerful magnifying glass to 
detect possible morphological changes in macrophages. All samples analysed had previously 
been collected at 3 and 6 weeks after right hemitorax irradiation (15 Gy) of C57BL/6 wild 
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type and CD73
-/-
 mice by Dr Therese Eldh (Tübingen). A striking finding in irradiated lungs 
was the presence of enlarged macrophages filled with non proteic content, which were barely 
found in control mice. Representative pictures are shown for both mouse strains in 
Fig. 3.12 A.  
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Fig. 3.12 Foamy macrophages in C57BL/6 wild type and CD73
-/- 
mice lungs. At 3 and 6 weeks after right 
hemithorax irradiation with 15 Gy or 0 Gy lung tissues were obtained and processed for electron microscopy. 
A) Representative light microscopy pictures of toluidine blue stained semithin sections (0.5 μm) from C57BL/6 
wild type (WT) and CD73
-/-
 mice showing foamy macrophages (black arrows) (magnification x1000; scale bar: 
10 μm). B) Electron microscopy picture of a foamy macrophage; some lipid droplets are pointed (black arrows) 
(magnification x7000; scale bar: 2 μm). C) Quantification of lipid loaded macrophages in semithin slices. Data 
represent relative mean percentage ± SD of lipid loaded macrophages to respective control groups (=100%)  
(≥3 different sections; 2 mice per group). 
 
Electron microscopy on lung tissue deriving from the same samples confirmed the presence 
of lipid droplets in the cytoplasm of macrophages and, in addition, in other not well defined 
locations, most probably corresponding to the lung interstitium or to the cytoplasm of other 
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resident cells (Fig. 3.12 B and data not shown). A quantification of lipid-loaded macrophages 
was completed scanning whole tissue on semithin sections and counting normal and foamy 
macrophages. Results of the analysis in WT and CD73
-/-
 mice are shown in Fig. 3.12 C as 
increases relative to respective controls (considered as 100 values). Both mouse strains 
showed a simultaneous and stable increase in the formation of foamy macrophages until 
week 6 p.i., but to a different extent. In details, IR led to an approximately 4-fold increase and 
a 10-fold increase of these cells in WT and CD73
-/-
 mice, respectively. This analysis, even 
though not statistically validated, suggests that IR disturbs lipid metabolism of macrophages 
in the lung tissue, in particular in the absence of CD73. 
It is largely accepted that, depending on the microenvironment and the inflammatory 
stimulus, macrophages have the ability to polarize toward a more inflammatory phenotype, 
named M1 or classically activated macrophages, or toward an alternative activation, namely 
the M2 phenotype, mainly involved in wound healing processes and inflammatory resolution. 
To characterize the role of macrophages in the regulation of the lung tissue response to IR, 
further analyses aimed at characterizing potential changes in the macrophage phenotype after 
whole thorax irradiation. At this purpose, tissue microarrays from C57BL/6 wild type and 
CD73
-/-
 mice were subjected to immunofluorescence staining and macrophage phenotype was 
distinguished either by the use of the anti-iNOS antibody for the classical activation, or by the 
anti-Arg1 and anti-IL-10rα antibodies for the alternative activation (Fig. 3.13). Histograms in 
Fig. 3.13 A represent percentages, relative to sham irradiated mice, that were obtained by 
counting F4/80
+
 cells positive for the phenotype marker of interest, in relation to F4/80-only 
positive macrophages. Exemplary immunofluorescence pictures are also shown (Fig. 3.13 B). 
In both strains, lung macrophages expressing iNOS, defined as M1 macrophages, showed 
only a slight increase in their percentage at late time points after irradiation, and at an earlier 
time point in CD73
-/-
 mice when compared to WT mice. Arg1 is produced in alternative to 
iNOS and characterizes a M2 phenotype. Presence or absence of CD73 seemed not to alter 
the induction of Arg1, in consideration of a similar trend observed in the percentage of 
double positive macrophages after irradiation, with early reductions, peaks at 12 weeks and 
late low levels of F4/80
+
Arg1
+
 cells. Interleukin-10 is an anti-inflammatory cytokine 
involved in the resolution of acute inflammation but has also been associated with fibrosis, as 
well as with alternative activation of macrophages. 
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Fig. 3.13 Macrophages and iNOS, or Arg1 or IL-10rα immunofluorescence staining. Lungs isolated at 3, 6, 
12, 24 and 30 weeks from irradiated and control C57BL/6 wild type (WT) and CD73
-/-
 mice were embedded in 
paraffin and used in the production of tissue microarrays. Sections of microarrays were immunostained with 
monoclonal antibodies anti-F4/80 in combination with anti-iNOS, or with anti-Arg1, or with anti-IL-10rα. 
Hoechst was used for nuclei counterstaining. A) Quantification of double positive macrophages in irradiated 
mice. Data represent mean percentages ± SD of double positive cells relative to respective control groups 
(=100%) (≥4 pictures per mouse; ≥2 mice per group) (*= 0 Gy vs 15 Gy; #= WT vs CD73-/-) (*,# p≤0.05; 
** p≤0.01; two-tailed unpaired t-test). B) Representative fluorescence microscopy pictures of the different 
stainings. F4/80
+
 cells (white arrows) and double positive macrophages (red arrows) are indicated 
(magnification x630; scale bar: 10 μm).  
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An increase in the expression of IL-10 receptor on macrophages can be considered as a 
marker for alternative activation, or at least for one subtype of M2 macrophages (Bogdan and 
Nathan, 1993; Gordon and Taylor, 2005; Moore et al., 2001; Sun et al., 2011). Whole thorax 
irradiation seemed to differentially affect the percentages of IL-10rα positive macrophages in 
the two mouse strains. F4/80
+
IL-10rα+ cells slowly increased in WT mice and reached a 13-
fold expansion at week 30 p.i., while in CD73 deficient mice only a slight increase in the 
amount of these cells was detected, with a peak at 24 weeks and subsequent decrease to 
percentages of control animals.  
These data indicate that a very distinct regulation of the macrophage compartment is 
accompanying the response to radiation injury, and that loss of CD73 leads to partial 
alteration of the ordinary tissue reaction to whole thorax irradiation. 
 
3.1.6.2 Flow cytometric analysis of macrophages - survival and lipid metabolism 
 
The analysis of lung macrophage morphology and phenotype, respectively performed on 
semithin sections and by the use of immunofluorescence on tissue microarrays, gave clear 
indications about changes occurring on these cells after radiation treatment. However, only 
small portions of tissue can be analysed using these approaches. Therefore, flow cytometry 
on whole lung was performed to further support results already obtained. 
Survival, proliferation and differentiation, as well as chemotaxis of mononuclear phagocytes 
are driven by the CSF-1 growth factor, and all members of the mononuclear phagocytic 
lineage express the CSF-1 receptor tyrosine kinase (Pixley and Stanley, 2004). The first 
investigation aimed at detecting a potential radiation-induced alteration of the expression of 
this key macrophage regulator. Results of the analysis are shown in Fig. 3.14. As observed in 
the absolute number of lung macrophages at 3 weeks p.i. (Fig. 3.6 E and F), the CSF-1R 
surface expression was equally and drastically downregulated at this time point in C57BL/6 
wild type and CD73
-/-
 mice, displaying normalized percentages corresponding to 23.6 ± 2.6 
and to 25.4 ± 1.7, respectively. At all the other time points included in the study only minor 
changes were detected, albeit WT mice seemed to progressively increase CSF-1R expression 
during the late fibrotic phase (24 and 30 weeks), especially in the infiltrating population. 
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Fig. 3.14 Analysis of CSF-1R expression on lung macrophages. C57BL/6 wild type (WT) and CD73
-/-
 mice 
received 0 Gy or 15 Gy whole thorax irradiation. Lung tissue isolated at 3, 6, 12, 24 and 30 weeks was used in 
flow cytometry staining. Alveolar (AM) and infiltrating macrophages (IM) were investigated for the expression 
of CSF-1R. Timelines show mean values ± SD of the geomean fluorescence intensity (MFI), normalized with 
respective MFIs of the same populations isolated from control animals. For each time point, the number of mice 
used is indicated within the bars (*= 0 Gy vs 15 Gy; #= WT vs CD73
-/-
) (# p≤0.05; ** p≤0.01; *** p≤0.001; 
two-tailed unpaired t-test).  
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Fig. 3.15 Analysis of CD36 expression on lung macrophages. C57BL/6 wild type (WT) and CD73
-/-
 mice 
received 0 Gy or 15 Gy whole thorax irradiation. Lung tissue isolated at 3, 6, 12, 24 and 30 weeks was used in 
flow cytometry staining. Alveolar (AM) and infiltrating macrophages (IM) were investigated for the expression 
of the scavenger receptor CD36. Timelines show mean values ± SD of the geomean fluorescence intensity 
(MFI) normalized with respective MFIs of the same populations isolated from control animals. For each time 
point the number of mice used is indicated within the bars (*= 0 Gy vs 15 Gy) (* p≤0.05; ** p≤0.01; 
*** p≤0.001; two-tailed unpaired t-test).  
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FACS analysis was also used to elucidate the dysregulation of lipid metabolism observed in 
lung macrophages after radiation treatment. In monocytes/macrophages one of the molecules 
responsible for oxLDL recognition, internalization and subsequent foam cell formation is the 
scavenger receptor CD36 (Rahaman et al., 2006). Therefore, expression of this protein was 
followed overtime on alveolar and infiltrating macrophages (Fig. 3.15). The 3 weeks time 
point was the most critical with regard to alveolar macrophages, when CD36 surface 
expression was reduced to less than 1/3
rd
 as compared to control cells, with no significant 
changes at later time points. On the contrary, most of the effects were noticed in infiltrating 
macrophages, which, in both mouse strains, constantly downregulated CD36 during the 
inflammatory phase. CD36 expression slowly reached control levels during the late phase, 
with a slight increase in WT mice at 30 weeks.  
 
3.1.6.3 Flow cytometric analysis of macrophages - Adenosinergic pathway  
 
As already mentioned, the absence of CD73 seemed to protect mice from late side effects of 
thorax irradiation. Due to the diffuse presence of this enzyme on the surface of several 
immune cell types and the immunoregulatory properties of adenosine, the expression of 
CD39 and CD73 was additionally investigated on lung macrophages over time.  
Once more, histograms of flow cytometric analyses show relative values of irradiated mice 
compared to respective sham irradiated animals. Whole thorax irradiation led to a distinct 
response in the regulation of the two ecto-enzymes on lung macrophages, in comparison to 
the one that has been already described for T lymphocytes. Indeed, significant overexpression 
of CD39 on alveolar macrophages (AM) and especially in C57BL/6 wild type mice was early 
occurring and persisted throughout the time points analysed, but little or no effects were 
observed on the infiltrating population (Fig. 3.16). In details, the two mouse strains showed a 
similar regulation of CD39 expression over time, with the only exception at 3 weeks, when a 
2.9-fold and 2.1-fold increases were measured in WT and CD73 mice, respectively. It is 
important to underline that the highest expression of CD39 specifically arose when this cell 
population was profoundly affected by IR (Fig. 3.6 E). 
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Fig. 3.16 Determination of CD39 and CD73 expression on macrophages by flow cytometry. C57BL/6 wild 
type (WT) and CD73
-/-
 mice received 0 Gy or 15 Gy whole thorax irradiation. At 3, 6, 12, 24 and 30 weeks time 
points lung tissue was used for cell isolation and antibody staining for alveolar or infiltrating macrophages in 
combination with anti-CD39 and anti-CD73 antibodies. To compare radiation effects in WT and CD73
-/-
 mice, 
timelines show mean values ± SD calculated in treated mice normalized with respect to control values. For each 
analysis the number of mice used is indicated within the bars (*= 0 Gy vs 15 Gy; #= WT vs CD73
-/-
) 
(*,# p≤0.05; **,## p≤0.01; *** p≤0.001; two-tailed unpaired t-test).  
 
A distinct regulation of CD73 was found in WT mice. At week 3 alveolar macrophages 
significantly decreased their surface expression of CD73 in comparison to control mice. The 
observed reduction was rapidly followed by a significant upregulation at week 6, when 
irradiation led to a 1.7-fold increase of CD73 on AM. The alveolar population gradually 
restored normal surface expression at later time points, with no significant changes in the late 
fibrotic phase. Again, infiltrating macrophages (IM), similarly to what has been depicted for 
the ecto-enzyme CD39, were not affected by irradiation in their expression of CD73. 
 It is worth to remark a discrepancy in the regulation of the two ecto-enzymes involved in the 
adenosine formation, with radiation altering CD39 surface expression on alveolar 
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macrophages throughout the time points analysed, and CD73 surface expression only in the 
very early phase of pneumonitis. 
 
3.1.6.4 Flow cytometric analysis of macrophages – M1 and M2 phenotype  
 
To corroborate data about macrophage activation obtained at a histological level, changes in 
the percentage of M1 and M2 macrophages in the lung tissue were determined by flow 
cytometry. Whole lung cells were stained for macrophages in combination with the markers 
MHCII and MMR to detect M1 or M2 phenotypes, respectively. Histograms in Fig. 3.17 A 
and B show timelines with values of fluorescence intensity measured in cells isolated from 
treated mice normalized with values of respective negative controls. The radiation treatment 
induced similar reactions in WT and CD73
-/-
 mice in regard to the expression of MHCII on 
alveolar macrophages. At week 3 p.i., an acute increase of 12.5-folds in WT mice and 11.9-
folds in CD73 mice was followed by the maintenance of increased, but lower levels of 
MHCII. While the inflammatory marker was still significantly upregulated at week 30 p.i. on 
CD73 deficient macrophages, WT mice showed only a trend in the increase of MHCII at this 
time point. No significant alterations in MHCII surface expression were detected in 
infiltrating macrophages in response to IR. 
As expected, alveolar macrophages showed a complete opposite regulation of the M2 marker 
MMR when compared to the M1 marker MHCII. At almost all time points analysed, a 
constant trend to a downregulation of this marker was measured in irradiated mice as 
compared to controls. At week 3 MMR was critically and differently reduced on macrophage 
surface in both WT and CD73
-/-
 mice. At later time points no or few changes were observed. 
Of note, MMR was largely upregulated in irradiated WT mice at week 30 p.i., pointing to the 
appearance of M2 macrophages in the fibrotic phase. Unfortunately, data concerning MMR 
staining for AM in CD73
-/-
 mice at 24 and 30 weeks are not available, so that a comparison 
between the two mouse strains at these time points is not achievable. The regulation of MMR 
expression in infiltrating macrophages, even though a significant difference between WT and 
CD73
-/-
 mice was observed during the pneumonitic phase, did not show drastic changes when 
comparing irradiated mice to the corresponding controls.  
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Fig. 3.17 Analysis of M1 and M2 phenotypes on lung macrophages by flow cytometry. C57BL/6 wild type 
(WT) and CD73
-/-
 mice received 0 Gy or 15 Gy whole thorax irradiation. Lung tissue isolated at 3, 6, 12, 24 and 
30 weeks was used in flow cytometry staining. Alveolar (AM) and infiltrating (IM) macrophages were 
investigated for the surface expression of MHCII (A) and MMR (B). Timelines show mean values ± SD of the 
geomean fluorescence intensity (MFI), normalized with respective MFIs of the same populations isolated from 
control animals. For each time point, the number of mice used is indicated within the bars (*= 0 Gy vs 15 Gy; 
#= WT vs CD73) (*,# p≤0.05; **,## p≤0.01; *** p≤0.001; two-tailed unpaired t-test).  
 
Altogether these data indicated that whole thorax irradiation triggers time-dependent changes 
in the macrophage compartment. Mainly alveolar macrophages of WT and CD73
-/-
 mice were 
differentially affected in their activation state, phenotype and surface expression of CD39 and 
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CD73, suggesting an active role of these cells in the progression of radiation-induced 
lung injury.  
It might be that the presence of immunosuppressive T cells or of specific T cell subsets is 
necessary to drive, influence or keep in check the activated cells from the innate and adaptive 
immune system and to control inflammation-associated tissue damage in the pneumonitic 
phase. However, an unregulated generation of immunosuppressive cells in the late phase may 
facilitate fibrosis development.  
 
3.2 The contribution of lymphocytes in radiation-induced pneumopathy 
 
To gain insight into the functional relevance of lymphocytes in radiation-induced 
pneumopathy RAG-2
-/-
 mice were enrolled in the study. This mouse strain is lacking mature 
T and B lymphocytes due to a total inability to initiate V(D)J rearrangement (Shinkai et al., 
1992) and therefore represents a useful tool to explore the innate immune response to 
radiation. 
 
3.2.1 Radiation induced changes in body weight and survival 
 
As previously described, following radiation treatment the body weight of RAG-2
-/-
 mice 
(RAG2) have been monitored weekly for the entire experimental span, and Δ weight values 
were compared with C57BL/6 wild type (WT) mice (Fig. 3.18 A).  
As expected, control WT and RAG-2
-/-
 mice continuously gained in weight until week 24, 
though to a different extent. Irradiated WT mice, as mentioned in par. 3.2, reached the 
maximum weight gain at week 22, thereafter slowly decreasing to a Δ value of 1.4 ± 3.1 g at 
week 24 p.i.. On the contrary, in the first week after treatment RAG-2
-/- 
mice showed an early 
weight loss, thereafter recovering until week 8, and with no relevant changes until week 21. 
In the last 3 weeks of the experiment, irradiated RAG-2
-/-
 mice had a rapid decrease in weight 
reaching approximately the mean starting body weight at week 24. The statistical comparison 
of Δ weight values showed highly significant differences between irradiated and respective 
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control mice, and interestingly also between irradiated WT and RAG-2
-/-
 mice, suggesting 
that the fibrotic disease may be more pronounced in the absence of T and B cells. 
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Fig. 3.18 Changes in body weight and survival in RAG-2
-/- 
mice. Weights and survival of RAG-2
-/-
 mice 
(RAG2) were monitored over time after 15 Gy whole thorax irradiation or sham irradiation, and compared to 
C57BL/6 wild type mice (WT). A) Changes in body weight are represented as mean delta values (Δ weight = 
weight at day X – weight at day 0). Significant difference was calculated using two-way ANOVA test (***,### 
p≤0.001). B) Kaplan-Meier survival curves showing survival percentages of irradiated RAG2 (n=17) and WT 
mice (n=12). The p value calculated by the log-rank (Mantel-Cox) test is indicated.  
 
 
Survival percentages of the two mouse strains mice were plotted in the Kaplan–Meier curve. 
As depicted in Fig. 3.18 B, WT and RAG-2
-/- 
mice exhibited similar mortality rates after 
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whole thorax irradiation, with percentages corresponding to 75.0 ± 12.5 and 58.9 ± 12.0, 
respectively. 
 
 
3.2.2 Histological changes of lung tissues in irradiated RAG-2-/- mice 
 
To assess damage after thorax irradiation, lung tissue of irradiated and control RAG-2
-/-
 mice 
was isolated and processed for histological analyses. As shown in Fig. 3.19 A, early tissue 
reactions to irradiation are not obvious by histological analysis of lung sections, even though 
an increase in inflammatory cell infiltrate is evident at 6 weeks post irradiation (solid arrows). 
Surprisingly, as a late event, all mice enrolled in the experiment showed enhanced collagen 
deposition and lung fibrosis already at week 24 after thorax irradiation with 15 Gy, therefore 
earlier in comparison to C57BL/6 wild type mice.  
The increased sensitivity to fibrosis of RAG-2
-/-
 mice was further evaluated by 
immunohistochemical staining of lung sections. Fibrotic areas within the tissue showed high 
positivity for the presence of the fibrotic markers α-SMA and TGF-β (Fig. 3.19 B). In 
contrast, sham irradiated mice clearly had normal lung structures, with no detectable tissue 
alterations indicative of fibrosis at this time point. 
In order to assess whether the increased sensitivity of RAG-2
-/-
 mice to radiation-induced late 
effects was exclusively a kinetic issue, or was possibly resulting in a higher degree of fibrosis 
compared to C57BL/6 wild type mice, a quantitative assessment of the extent of lung fibrosis 
was made. At this purpose, the percentage of fibrotic areas and the number of fibrotic foci per 
mouse were quantified in both strains. Fibrosis affected almost 20 % of the lung surface in 
RAG-2
-/-
 mice (18.0 ± 13.6 %), whereas less than 10 % of lung tissue was fibrotic in WT 
mice (6.5 ± 7.8 %). Median values represented in the scatter dot plot are equal to 3.1 % for 
WT mice and 10.4 % for RAG-2
-/-
 mice (Fig. 3.20 A). The tendency to a higher extent of 
fibrosis in RAG-2
-/- 
mice was associated with a significant increase in the number of fibrotic 
foci in respect to WT mice, as shown by median values corresponding to 11.7 and 4.7, 
respectively (Fig. 3.20 B). 
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Fig. 3.19 Lung histological changes in RAG-2
-/- 
mice. Lung tissues were obtained 3, 6, 12 and 24 weeks (w) after 
whole thorax irradiation with 15 Gy or 0 Gy. A) Representative light microscopy pictures of hematoxylin and eosin 
(H&E) and Masson-Goldner trichrome stained lung sections at all time points analysed. Increased presence of 
inflammatory cells (solid arrows) was found in lung sections of mice at 6 weeks post irradiation (magnification 
x100; scale bar: 100 μm). B) Representative light microscopy pictures of immunohistochemical stainings for the 
markers α-SMA and TGF-β on sections of control and irradiated mice at 24 weeks (magnification x100; scale bar: 
100 μm). Positive staining within fibrotic areas is indicated by solid arrows.  
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Fig. 3.20 Quantitative analysis of fibrosis in C57BL/6 wild type and RAG-2
-/- 
mice. Lung sections were obtained 
from C57BL/6 wild type (WT) and RAG-2
-/-
 (RAG2) mice 24 weeks after 15 Gy whole thorax irradiation, stained 
with H&E and analysed for the amount of fibrosis and the number of fibrotic foci. A) Quantification of fibrosis 
extent in mice 24 weeks after irradiation expressed as percentage of lung area showing fibrosis. B) Quantification of 
fibrotic foci in mice 24 weeks after irradiation. Data represent median values obtained in ≥3 sections per mouse with 
a minimum distance of 250 µm in depth (# p≤0.05; two-tailed unpaired t-test). 
 
3.2.3 Cellular changes of lung tissues in irradiated RAG-2-/- mice 
 
To elucidate how the lack of lymphocytes could impact on the infiltration of immune cells in the 
lung and to independently confirm the increased infiltration observed by histological staining at 
6 weeks p.i., tissues from RAG-2
-/-
 mice were evaluated by flow cytometry. Due to the absence 
of cells belonging to the adaptive immune system, exclusively the presence of total leukocytes, 
macrophages and granulocytes could be compared to the results obtained in C57BL/6 wild type 
(WT) mice. At 6 weeks (Fig. 3.21 A), RAG-2
-/-
 mice showed in all cell populations analysed a 
similar tendency as the one observed in WT mice. In detail, the percentage of leukocytes in 
RAG-2
-/-
 mice increased, whereas granulocyte population was not affected by irradiation. 
Alveolar macrophages showed a limited increase after treatment whereas a slight but significant 
infiltration of newly recruited macrophages was noted after 15 Gy irradiation.  
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Fig. 3.21 Determination of leukocyte content in lung tissue. C57BL/6 wild type (WT) and RAG-2
-/-
 mice (RAG2) received 0 Gy or 15 Gy whole thorax 
irradiation. At 6 (A) and 24 (B) weeks time points lung tissue was digested and used for cell isolation and antibody staining for total leukocytes (CD45
+
), 
granulocytes (Gr1
+
) and alveolar (AM - F4/80
+
CD11c
+
) or infiltrating (IM - F4/80
+
) macrophages. Shown are mean values ± SD of percentages calculated on 
total lung cells (TLCs). Cells of ≥2 mice per group were analyzed (* p≤0.05; *** p≤0.001; two-tailed unpaired t-test to respective controls). 
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When analysing lung immune cells at 24 weeks post irradiation (Fig. 3.21 B), once again 
RAG-2
-/-
 mice showed a similar tendency to the one seen in WT mice. The percentage of 
leukocytes significantly increased of approximately 1.6-folds in both strains after irradiation, 
and a slight increase was detected in the amount of Gr1 positive cells and macrophages. 
Remarkably, CD45 positive cells, alveolar macrophages, as well as infiltrating macrophages 
were significantly lower in RAG-2
-/-
 mice as compared to WT mice, respectively with p values 
of 0.0004, 0.0102 and 0.0014 as measured by two-way ANOVA test. In the specific alveolar 
macrophages showed 1.9-fold and 1.3-fold increase in WT and RAG-2
-/- 
mice respectively,
 
while infiltrating macrophages 1.2-fold and 1.6-fold increase in WT and RAG-2
-/- 
mice, 
respectively. 
 
3.2.4 Macrophage characterization 
 
In RAG-2
-/-
 mice the lack of B and T lymphocytes leads to an inflammatory response 
exclusively driven by cells of the innate immunity. Thus, it was important to determine whether 
macrophages, despite a little change in their percentages, could display altered protein 
expression, focusing on the same markers analysed in C57BL/6 wild type and CD73
-/-
 mice 
(par. 3.1.6.2, 3.1.6.3 and 3.1.6.4). In Fig. 3.22, regulation of CSF-1 receptor (A) and CD36 
scavenger receptor (B) on RAG-2
-/-
 alveolar and infiltrating macrophages is shown as relative 
expression to respective values obtained in sham irradiated mice. In detail, alveolar 
macrophages of WT mice and RAG-2
-/-
 mice displayed a similar expression of CSF-1R at 6 
and 24 weeks p.i., but an upregulated expression of the scavenger receptor at 24 weeks p.i..  
The scavenger receptor CD36 was indeed 1.4-fold upregulated on alveolar macrophages of 
RAG-2
-/-
 mice, while as previously shown, no changes of this marker were found on lung 
macrophages of WT mice. Infiltrating macrophages of RAG-2
-/-
 mice did not show changes 
overtime in their expression of CSF-1R and CD36.  
 
To explore the impact of whole thorax irradiation on the adenosinergic pathway in the absence 
of B and T lymphocytes, lung macrophages were additionally analysed for surface expression 
of CD39 and CD73. Fig. 3.23 shows comparison of average values ± SD between RAG-2
-/-
 and 
WT mice. Also in RAG-2
-/-
 mice alveolar macrophages were more affected by irradiation 
compared to infiltrating macrophages. 
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Fig. 3.22 Determination of macrophage characteristics. C57BL/6 wild type (WT) and RAG-2
-/-
 mice (RAG2) 
received 0 Gy or 15 Gy whole thorax irradiation. Alveolar macrophages (AM) and infiltrating macophages (IM) 
were investigated at 6 and 24 weeks time points for the expression of CSF-1 receptor (A) and CD36 scavenger 
receptor (B). Shown are mean values ± SD of the geomean fluorescence intensity (MFI), normalized with 
respective MFIs of the same populations isolated from control animals. Cells of ≥2 mice per group were analyzed 
(*= 0 Gy vs 15 Gy; #= WT vs RAG2) (*,# p≤0.05; two-tailed unpaired t-test).  
 
 
Alveolar macrophages of RAG-2
-/-
 mice showed even a higher but not significant increase (2.3-
folds) in the expression levels of CD39 compared to those isolated from WT mice (1.6-folds) at 
24 weeks.  
 
Surprisingly, whole thorax irradiation failed to upregulate CD73 in alveolar macrophages of 
RAG-2
-/-
 mice at the two time points analysed, in contrast to the high upregulation of this 
enzyme observed in WT mice at 6 weeks. In infiltrating macrophages almost no differences 
were found in the surface expression of CD73 and CD39 in both mouse strains in response to 
whole thorax irradiation, with the only exception of a slight CD73 downregulation in RAG-2
-/-
 
mice at 24 weeks (Fig. 3.22 B). 
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Fig. 3.23 Determination of CD39 and CD73 expression on lung macrophages. C57BL/6 wild type (WT) and 
RAG-2
-/-
 mice (RAG2) received 0 Gy or 15 Gy whole thorax irradiation. Alveolar macrophages (A) and 
infiltrating macophages (B) were investigated at 6 and 24 weeks time points for the expression of CD39 and 
CD73. Results are compared with values obtained in C57BL/6 wild type mice (WT). Shown are mean values ± SD 
of percentages of CD39 or CD73 surface expression on macrophage cells, normalized with respective values 
obtained from sham irradiated mice. Cells of ≥2 mice per group were analyzed (*,# p≤0.05; ** p≤0.01; 
*** p≤0.001; two-tailed unpaired t-test)  
 
 
To gain insight into potential differences in macrophage activation state in irradiated WT and 
RAG-2
-/-
 mice, it was analysed whether whole thorax irradiation would differentially affect 
polarization of macrophages into pro-inflammatory (M1) or pro-regenerative (M2) phenotypes. 
As shown in Fig. 3.24, alveolar macrophages of RAG-2
-/-
 and WT mice displayed an 
inflammatory M1 phenotype as an early and late response, almost reaching a 4-fold increase in 
MHCII surface expression relatively to control MFIs at 24 weeks p.i.. At all time points, the 
extent of MHCII upregulation was significantly higher in RAG-2
-/-
 mice compared to the one 
detected in WT mice. Effects of radiation on the M2 polarization were comparable in the two 
mouse strains, though a significant increase (1.2-folds) in alternative activation was present 
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only in RAG-2
-/-
 mice at 6 weeks p.i.. Newly recruited macrophages seemed not to polarize 
towards an M1 or M2 phenotype in response to tissue irradiation, although a tendency of 
MHCII upregulation was noted at the time points under investigation (data not shown).  
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Fig. 3.24 Determination of alveolar macrophage polarization. C57BL/6 wild type (WT) and RAG-2
-/-
 mice 
(RAG2) received 0 Gy or 15 Gy whole thorax irradiation. Alveolar macrophages were investigated at 6 and 24 
weeks p.i. for the expression of MHCII and MMR. Shown are mean values ± SD of the geomean fluorescence 
intensity (MFI) normalized with respective MFIs of the same populations isolated from sham irradiated mice. 
Cells of ≥2 mice per group were analyzed (*,# p≤0.05; **,## p≤0.01; two-tailed unpaired t-test). 
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4 Discussion 
 
Radiation therapy is one of the most important approaches used in the treatment of patients 
with thoracic and hematologic malignancies. Albeit many progresses have been made in the 
field of radiotherapy, this therapeutic intervention can generate indirect and adverse effects on 
normal host tissue. At present, radiation-induced injuries to the lung, known as pneumonitis 
and fibrosis, still constitute a major complication in the treatment of thorax-associated cancer 
patients. To date, the molecular mechanisms governing the onset and progression of 
radiation-induced early and late side effects on the lung tissue are not entirely understood. 
Moreover, conflicting results have been obtained in the effort to explain a direct link between 
inflammation and fibrosis development after lung injury. 
Therefore, within the present work a mouse model of whole thorax irradiation was used to 
investigate the role of the CD73/adenosine system of the innate and adaptive immune responses 
in the pathogenesis of radiation-induced pneumonitis and fibrosis with the ultimate goal to 
identify novel therapeutic targets for prevention or treatment of early and late radiation-induced 
lung injuries. 
 
The present work shows for the first time that loss of CD73 protects from radiation-induced 
fibrosis and that lack of mature T and B cells in RAG-2
-/-
 mice causes increased collagen 
deposition and fibrosis. Notably, loss of CD73 or of mature T and B cells was associated with 
alterations in the polarization/activation state of specific immune cells suggesting a role of the 
innate and adaptive immune systems in the pathogenesis of radiation-induced fibrosis.  
 
In more detail, loss of CD73 was associated with a decreased sensitivity to radiation-induced 
lung fibrosis. Despite a clear trend to decreased collagen deposition in the irradiated lung tissue 
of CD73
-/-
 mice, the semiquantitative evaluation of the extent of lung fibrosis in the two strains 
failed to detect significant differences between C57BL/6 wild type (WT) and CD73
-/-
 mice. 
This may at least be partially due to some “non-responders” in the WT strain and to the low 
number of animals analysed. It will be necessary to corroborate the fibrotic changes observed at 
histological levels with the use of methods such as hydroxyproline or Sircol assays, in order to 
have a whole lung quantitative analysis of collagen content, and thus of fibrosis development. 
Nevertheless, deficiency of CD73 was not only associated with decreased collagen deposition 
but also with a reduced loss of body weight in the irradiated mice when compared to WT mice. 
This observation corroborates a better general health condition in CD73 deficient mice. In both 
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strains, few irradiated mice died within the first 10 weeks p.i., and thus probably due to 
radiation-induced pneumonitis. However, death rates were rather similar during the 
pneumonitic phase between WT and CD73
-/-
 mice. In line with these findings, histological 
analyses did not show marked differences in the two strains during the pneumonitic phase post 
irradiation (p.i.) (3-12 weeks). Some mice also died during the time of expected fibrosis 
development, resulting in a final survival rate that was slightly higher in CD73
-/-
 mice. 
However, 15 Gray (Gy) whole thorax irradiation is usually not sufficient to induce high death 
rates, although extensive collagen deposition and fibrosis development can be observed.  
In addition, the immunostaining results showed that lung sections of WT animals were highly 
positive for the fibrotic markers α-SMA and TGF-β, whereas CD73 deficient mice showed 
normal distribution of α-SMA (around blood vessels and bronchial airways), and no or weak 
staining for TGF-β. These results further corroborate that the two strains differently respond to 
whole thorax irradiation and, in particular, that CD73
-/-
 mice are less sensitive to 
radiation-induced lung fibrosis. Even more important, it was shown for the first time that in 
WT mice whole thorax irradiation triggers a time-dependent increase in lung tissue hypoxia, 
with macrophages being positively stained already at early time points p.i.. Thus, the presence 
of hypoxia as a consequence of radiation-induced lung injury could result from an increased 
oxygen consumption by activated macrophages and, in a later phase, from a more general 
impairment of the normal blood perfusion and gas exchange within the fibrotic lung tissue. 
Temporal changes in tissue oxygenation have also been found in lung tissue of rats receiving 
28 Gy hemithorax irradiation. At week 6 p.i. moderate hypoxia was observed, with gradual 
increase to severe hypoxia until week 20 p.i.. In these reports, authors proposed hypoxia to be 
one of the driving forces in initiating and perpetuating radiation induced lung injury 
(Fleckenstein et al., 2007b; Vujaskovic et al., 2001). Moreover, hypoxia-inducible factor-1α 
(HIF-1α) deficient mice showed reduced collagen and α-SMA levels in a model of liver fibrosis 
(Moon et al., 2009). The transcription factor HIF-1α is the master regulator of gene expression 
at low oxygen levels and its activity in normoxic condition is tightly silenced. It is important to 
mention that mice carrying a mutation in the von Hippel–Lindau (VHL) ubiquitin ligase, which 
is involved in the oxygen-dependent proteasomal degradation of HIF-1α, show pulmonary 
remodeling, macrophage infiltration and fibrosis in the elderly as a consequence of elevated 
HIF-1α activity (Hickey et al., 2010). The upregulation of HIF-1α was also observed in a 
mouse model of bleomycin (BLM) induced fibrosis during the development of the disease 
(Tzouvelekis et al., 2007). Therefore, hypoxia could have a major role in the development of 
radiation-induced fibrosis observed in WT mice in the present study, resulting from 
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hypoxia-mediated activation of HIF-1α signalling and HIF-1α triggered effects. Of note, 
irradiated CD73
-/-
 mice showed a delayed onset and lower levels of tissue hypoxia in 
association with minimal fibrosis. These observations suggest that hypoxia per se is not 
sufficient to trigger fibrosis. Rather, the presence of a HIF-1α binding motif in the CD73 gene 
promoter may imply that the expression of this ecto-enzyme is upregulated as a consequence of 
tissue hypoxia, thus contributing to increased extracellular adenosine levels in hypoxic tissues 
(Colgan et al., 2006; Synnestvedt et al., 2002). In conclusion, the early hypoxia after 
radiation-induced lung injury may, via upregulation of CD73, chronically increase Ado levels 
and shift the balance towards pro-fibrotic events, which can in turn exacerbate hypoxia. Thus, 
CD73 may function as a main link between hypoxia, adenosine and fibrosis development, and 
its absence could be responsible for the protection of CD73
-/-
 mice from radiation-induced 
pulmonary fibrosis. To prove this hypothesis it would be important to measure Ado content in 
the lung of irradiated WT and CD73
-/- 
mice throughout the experimental span. 
As mentioned before, many studies have shown a key role of the components of Ado 
metabolism and signalling in respect to chronic lung pathologies in humans and animal models.  
In contrast with the obtained results, in a BLM model of acute pulmonary fibrosis CD73 
deficient mice challenged with intratracheal BLM displayed enhanced collagen production and 
deposition when compared to CD73 proficient mice, pointing to a tissue-protective role of the 
CD73/Ado system (Volmer et al., 2006). Most likely during acute lung injury, increased Ado 
could be beneficial mainly because of its anti-inflammatory effects, whereas in the radiation 
model of lung injury chronic elevation of Ado levels could favour the progression to fibrosis. 
However, the differences in Ado-mediated effects may also largely depend on the diverse 
activities and distribution of Ado receptors; for example, the high-affinity A1 and the low-
affinity A2B receptors have been identified as mediators of anti-inflammatory/tissue protective 
and pro-fibrotic/tissue destructive effects of adenosine, respectively (Sun et al., 2005; Sun et 
al., 2006). 
 
In the attempt to find a link between radiation pneumonitis and fibrosis, it was next necessary 
to show whether the loss of the CD73/Ado system could differently affect the inflammatory 
response following thorax irradiation, thereby being responsible for the delayed tissue 
protection found in CD73 deficient mice. A significant infiltration of leukocytes started at week 
6 p.i. in irradiated WT and CD73
-/-
 mice. Because CD73 expression on endothelial cells has 
been implicated in tissue barrier function (Koszalka et al., 2004; Lennon et al., 1998), an 
increased recruitment of immune cells after injury in CD73 deficient mice was expected 
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(Zernecke et al., 2006). However, CD73
-/-
 mice displayed the same ability as WT mice to 
recruit immune cells to the site of injury. In support of these data, CD73 has been proposed to 
mediate cell adhesion processes, in that antibodies directed to CD73 could interfere with the 
binding of human lymphocytes to cultured endothelium (Airas et al., 1995). In addition, CD73 
deficient mice maintained higher levels of cellular infiltrates, mainly granulocytes and T cells, 
until week 30 p.i. suggesting a different ability in the resolution of inflammation after whole 
thorax irradiation compared to WT mice.  
The early drop in T cell and macrophage numbers at week 3 p.i. corroborated a suggested 
immunosuppressive action of whole thorax irradiation. Surprisingly, the lack of functional 
CD73 resulted in a less pronounced immunosuppressive effect at this time point. This 
observation suggests for the first time that that the lack of endogenous CD73 leads to a lower 
sensitivity of lymphocytes to radiation-induced cell death, or to an accelerated 
recruitment/proliferation of macrophages and T cells after whole thorax irradiation.  
Interestingly, radiation effects on CD3
+
 cells mainly occurred during the pneumonitic phase 
and confirmed the radiation-induced increase in T lymphocytes, mainly CD4
+
 T cells, typically 
observed in cancer patients in the so-called alveolar lymphocytosis (Cordier et al., 1984; 
Gibson et al., 1988; Martin et al., 1999; Nakayama et al., 1996; Roberts et al., 1993). In 
contrast, in normal conditions C57BL/6 wild type and CD73
-/-
 mice have similar cellular 
composition of lymphoid organs and lymphocytes show comparable proliferative capacity (data 
not shown)(Thompson et al., 2004). 
However the subtle differences observed in the lung immune cell composition were not 
sufficient to explain the distinct radiation responses of C57BL/6 wild type and CD73
-/-
 mice 
with respect to fibrosis development. Therefore potential differences in radiation-induced 
changes in T cell functions were investigated focusing on the expression of the adenosinergic 
pathway at first, and in a second step on T cell polarization. CD39 and CD73 expression on 
CD3
+
 and CD4
+
 T cells was differentially regulated in response to whole thorax irradiation, 
with CD73 being upregulated in the pneumonitic phase and CD39 in the fibrotic phase. In 
contrast, whole thorax irradiation did not largely affect the surface expression of the 2 
ecto-enzymes on CD8
+
 T cells. Interestingly, local changes affecting T lymphocytes in regard 
to sensitivity and adenosinergic pathway regulation were mirrored in T cells isolated from 
spleen and cervical lymph nodes of irradiated mice. These data show for the first time that 
whole thorax irradiation not exclusively affects the local T cell population, but also drives 
adaptive changes in other biological compartments besides the lung. Even more important, 
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these data demonstrate radiation-induced local changes in the adenosinergic pathway regulation 
on specific T cell populations.  
CD39 and CD73 are part of the immunosuppressive machinery of regulatory T cells (Treg) 
(Deaglio et al., 2007; Kobie et al., 2006). Thus, a differential expression of CD73 and CD39 on 
(local) CD4
+
 T cells of irradiated mice may reflect major changes in the immunoregulatory 
repertoire of the cells recruited to and/or present in the irradiated lung tissue. Effectively, and 
mainly in WT mice, lung and peripheral Treg cells increased at 3 weeks post irradiation. In light 
of recent reports about the increased radioresistance of these cells both in vitro and after whole 
body irradiation in vivo (Cao et al., 2009; Qu et al., 2010), it is not surprising that the decrease 
in CD4
+ 
T cells at this time point is accompanied by a higher percentage of Treg cells. 
Altogether, these results show for the first time local and systemic alterations in the Treg cell 
compartment upon whole thorax irradiation, and suggest that upon radiation-induced lung 
injury regulatory T cells are recruited in loco in the early phase of pneumonitis, therefore being 
partly responsible for the observed upregulation of the adenosinergic pathway's members on 
T lymphocytes. The absence of CD73 in this regulatory system could be responsible for the 
ongoing local inflammation and the sustained Treg cell levels observed in the periphery, as seen 
in CD73
-/-
 mice.  
The role of Treg cells during fibrogenic processes is still controversial. On one hand, Treg cells 
may form an important homeostatic mechanism for tissues injured by radiation dampening TH 
responses, regulating detrimental T cell activities, and eventually avoiding excessive immune 
responses. On the other hand, due to their ability to secrete anti-inflammatory cytokines, such 
as IL-10 and TGF-β, they can contribute to stimulate fibroblast proliferation and activation, as 
well as collagen deposition. In addition, the ability of regulatory T cells to generate adenosine 
through the CD39/CD73 pathway should not be underestimated in this complex scenario. 
During acute lung injury (ALI) after intratracheal administration of LPS, Treg cells played a 
central role in the resolution of ALI fibroproliferation by reducing fibrocyte recruitment 
(Garibaldi et al., 2013). In a more elegant study, the importance of CD73 on Treg cells was 
pointed out as essential to mediate endogenous protection from ALI. In this report, lung injury 
of CD73 deficient mice or RAG deficient mice adoptively transferred with CD73
-/- 
Treg cells, 
was more prominent than the one showed by wild type mice or RAG deficient mice adoptively 
transferred with CD73
+/+ 
Treg cells (Ehrentraut et al., 2013). Nevertheless, ALI is characterized 
by severe inflammation, therefore it cannot properly represent the specific environmental 
conditions which drive chronic fibrogenic processes. For example in a model of silica-induced 
lung fibrosis, it was shown that recruitment and persistence of Treg cells in the lung contributed 
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to pulmonary fibrosis, whereas depletion of Treg cells could attenuate the progress of lung 
fibrosis (Liu et al., 2010; Lo Re et al., 2011). A very recent study of BLM-induced lung fibrosis 
demonstrated that Treg cells depletion with anti-CD25
+
 antibody during the early, intermediate, 
and late phases of the disease could differently influence the outcome of fibrosis. In detail, 
inflammatory changes and collagen deposition were ameliorated by early depletion of 
CD4
+
CD25
+
 Treg cells and worsened by late depletion of CD4
+
CD25
+
 Treg cells. The authors 
suggested that the early suppressive activity of Treg cells is detrimental, while the late 
suppressive activity of Treg cells is beneficial in the chronic stage of the disease (Boveda-Ruiz 
et al., 2013). In contrast, preliminary experiments in our lab do not support the above 
hypothesis: DEREG mice depleted in the first 3 weeks p.i. of Treg cells developed fibrosis at the 
same extent than irradiated DEREG mice with functional Treg cells until 30 weeks p.i. (data not 
shown). At this point, it is relevant to underline that the use of the BLM model rather than the 
irradiation model of lung fibrosis, might not be the right tool to investigate molecular and 
cellular mechanisms involved in the pathogenesis of early and late side effects of radiotherapy 
in lung tissue in detail.  
Notably, further own results demonstrate a second increase of Treg cells during the fibrotic 
phase in WT mice (Supplementary data, Fig 7.1). TGF-β is known to contribute to the 
maintenance of nTreg cells in the periphery and induces Foxp3 in naive T cells in the periphery 
(iTreg) (Chen et al., 2003). Therefore in a TGF-β-rich microenvironment like the one observed 
at 24 and mainly at 30 weeks p.i. in WT mice, could be responsible for the expansion of Treg 
cells at this time point. Fibrosis development after whole thorax irradiation was also 
accompanied by increased hypoxia, which conversely is known to inhibit Treg cell 
differentiation through an active process that targets Foxp3 protein for degradation, in addition 
to directly promote TH17 differentiation (Dang et al., 2011; Sakaguchi et al., 2008). In the 
present study, no analysis of TH17 cells has been done. Whether alterations in the TH17/Treg cell 
balance could influence the chronic development of fibrosis will require additional 
investigations. However it should also be considered that, within a fibrotic lung, areas with 
different microenvironments and with different functional immune cell subsets will coexist, 
therefore spatially confined and distinct compartments in the tissue itself may be defined. It is 
highly likely that fibrotic areas comprehend molecular and cellular mediators very diverse from 
non-fibrotic areas. 
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Whole thorax irradiation could alter many of the features of the T lymphocyte population, 
therefore it was interesting to analyze radiation-induced changes on the most represented 
immune cell population in the lung: macrophages.  
It is widely demonstrated that lung irradiation leads to resident macrophage depletion followed 
by rapid expansion of this population through recruitment of new cells or local proliferation, 
and a further increase in the late fibrotic phase (Chiang et al., 2005; Hong et al., 2003). 
Therefore, the early drop in macrophage percentages at week 3 p.i. was expected due to the 
cytotoxic damage of radiation. However, percentages of AM isolated from CD73
-/-
 mice were 
significantly higher as compared to AM of irradiated WT mice, suggesting again a lower 
sensitivity to radiation or an accelerated recruitment/proliferation of macrophages after whole 
thorax irradiation in these mice. Possibly, the lower sensitivity may lead to a faster or more 
efficient resolution of radiation-induced responses in CD73
-/-
 mice (24 weeks p.i.). On the 
contrary, the progressive increase of AM in irradiated WT mice associated to fibrosis 
development (24 and 30 weeks p.i.) suggests the persistence of the inflammatory/damaging 
stimulus. Thus, macrophage responses might be prolonged and, at the same time, these cells 
may actively contribute to the fibrogenic process. 
Despite their sensitivity to radiation, alveolar macrophages are the first line of defense and are 
immediately involved in the removal of apoptotic cells and debris, as well as in the production 
of cytokines such as IL-1, TNF-α and PDGF-β (Coggle et al., 1986; Hong et al., 2003; Morgan 
and Breit, 1995; Rubin et al., 1992). A common feature of lung macrophages early after thorax 
irradiation is their foamy appearance. This lipid-filled and enlarged macrophages have been 
described in the BALF or in the tissue during acute pneumonitis following thoracic irradiation 
both in human and in animal models (Chiang et al., 2005; Gross and Balis, 1978; Hong et al., 
2003). Although it was not completely unexpected to find these characteristic cells, here it is 
shown for the first time that lipid loaded macrophages appear in the lung tissue up to 6 weeks 
p.i., and that also other resident cells contain lipid droplets (Cappuccini et al., 2011). This 
observation suggested that IR disturbs lipid metabolism in the lung tissue. Remarkably, 
C57BL/6 wild type and CD73
-/-
 mice exposed to hemithorax irradiation showed a different 
amount of foamy macrophage at 3 weeks p.i. with a simultaneous increase at 6 weeks p.i.. The 
elevated amount of lipid-loaded cells in CD73
-/-
 mice suggests that IR affects lipid 
accumulation/use of macrophages in particular in the absence of CD73. Generally, lipid 
accumulation in macrophages represents a hallmark of early atherosclerotic lesions (Brown and 
Goldstein, 1983; Libby, 2002) and has also been described following Mycobacterium 
tubercolosis infections (Hernandez-Pando et al., 1997). Furthermore, presence of foamy cells in 
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areas of degenerating brain has long been known (Virchow, 1867). The presence of foamy 
macrophages in the BALF suggested that these cells may represent the alveolar pool rather than 
interstitial or infiltrating macrophages. In support of that assumption, no correlation was found 
between foamy cells and Mac-1 cell positivity, a marker with higher expression on inﬁltrating 
macrophages compared to mature tissue macrophages (Chiang et al., 2005; Dougherty and 
McBride, 1984; Duan et al., 2012; Hong et al., 2003). It might be that in CD73
-/-
 mice, due to 
the reduced radiation-sensitivity described for alveolar macrophages compared to WT mice, a 
higher amount of these cells is available for the uptake of oxidized lipids. Whether the loss of 
CD73 could directly influence macrophages in their ability to accumulate/degrade cellular 
lipids has still to be clarified. However, adenosine binding to A2A receptor has been shown to 
stimulate the expression of proteins involved in the reverse cholesterol transport, thereby 
inhibiting foam cell formation in macrophages (Reiss et al., 2004). 
In general, foam cells formation is the consequence of an excessive intracellular deposition of 
cholesterol due to an alteration in the uptake mainly of oxidized low-density lipoproteins 
(LDL) by macrophage scavenger receptors. A second main mechanism leading to a 
dysregulated intracellular cholesterol homeostasis is depending on mediators of cholesterol 
efflux (Luo et al., 2010). The scavenger receptor CD36 has been indicated as key factor in 
foam cell formation (Rahaman et al., 2006) and it is upregulated in a time- and dose-dependent 
manner by IR treatment in cultured blood-derived macrophages; furthermore, irradiation is able 
to increase the uptake of oxLDL in those cells (Katayama et al., 2008). In own preliminary 
experiments, bone marrow derived macrophages (BMDM) freshly isolated from CD73
-/-
 mice 
displayed higher CD36 expression in comparison to BMDM of WT mice (data not shown); 
therefore it was hypothesized that this receptor may be relevant for lipid uptake after whole 
thorax irradiation. Unfortunately, FACS analysis failed to show a direct correlation between 
CD36 and the presence of foamy macrophages at 3 and 6 weeks p.i. suggesting that other 
scavenger receptors, such as scavenger receptors A (SR-A) and class B type I (SR-BI), or a 
defective cholesterol efflux might play a major role during this phase. In support of the 
comparable surface regulation of CSF-1R and CD36 in lung macrophages after whole thorax 
irradiation, is that one effect of macrophage colony stimulating factor (M-CSF) on 
macrophages is the increase in cholesterol concentration in the cells, suggesting a direct link 
between the 2 receptors and a similar response to radiation (Dushkin, 2012).  
Although in the present study the responsible mediators were not identified, this is the first time 
that the impact of lung irradiation on lipid metabolism and generation of foamy macrophages 
has been addressed. Previous publications have tried to identify the activation state of these 
 Discussion 4 
 
 | 93  
 
foamy macrophages with no clear results. Foamy macrophage formation has been associated 
with an M1 polarization state in inflammatory processes. Others suggested that these cells 
actively participate to the resolution of inflammation and that M2 macrophages have a higher 
expression of CD36, as well as of transporters implicated in cholesterol efflux (Dushkin, 2012; 
Oh et al., 2012; Pradel et al., 2009). In the effort of shedding light on the role of these peculiar 
cells in the radiation-induced pnumopathy, and to explain the differences found in the amount 
of foamy macrophages in C57BL/6 wild type and CD73
-/-
 mice, the polarization state of the 
macrophage compartment was evaluated. Data from immunofluorescence staining on tissue 
microarrays revealed an early reduction in the M2 phenotype (Arg1) accompanied by a slight 
increase of the M1 phenotype (iNOS) compared to control animals. The Arg1 positive 
macrophages expanded particularly at 12 weeks p.i. in WT and CD73
-/-
 mice, being 
underrepresented at later time points when the F4/80
+
IL-10rα+ cells increased, especially in 
irradiated WT mice at 30 weeks. Notably, percentages of IL-10rα+ M2 macrophages were only 
increased in WT, but not in CD73
-/-
 mice. The 13-fold increase in IL-10 receptor positive 
macrophages observed could indicate an IL-10-rich lung microenvironment during fibrosis 
development in these mice. In support of this finding, many reports have described a role of 
IL-10 in fibrotic lung diseases in general (Barbarin et al., 2005; Lee et al., 2002; Sun et al., 
2011). Animals overexpressing IL-10 in the lung tissue showed induction of alternatively 
activated macrophages and irreversible lung fibrosis (Sun et al., 2011) and in other animal 
models, fibrosis was reduced when development of M2 was inhibited (Laskin et al., 2011). 
Moreover, TGF-β plays a critical role in promoting alternative macrophage activation (Gong et 
al., 2012), therefore the higher levels of this cytokine in WT mice as compared to CD73 
deficient mice at 30 weeks further strengthen histological results.  
Phenotypic differences were partially corroborated investigating whole lung macrophages 
using flow cytometry. Differential regulation of the markers MHCII and MMR was used to 
characterize M1 and M2 macrophages respectively. Surface expression of MHCII dramatically 
increased a 3 weeks, whereas a severe decrease in MMR expression in WT and CD73
-/-
 mice 
was observed at that time point. As hypothesized, during the fibrotic phase macrophages of WT 
mice seemed to switch from M1 to M2 phenotype, while alveolar macrophages from CD73
-/-
 
mice showed a sustained pro-inflammatory phenotype until this late time point. This 
observation corroborated the stably high percentages of the F4/80
+
iNOS
+
 population seen in 
CD73 deficient mice in the immunofluorescence analyses. The presence of inflammatory 
macrophages in CD73
-/-
 mice at late time points (24 and 30 weeks p.i.) suggests that these mice 
may possibly be characterized by continued (mild) inflammation. 
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The striking differences in the polarization of lung macrophages between WT and CD73
-/-
 mice 
are perfectly in line with the current hypothesis on the role of macrophages in fibrotic diseases. 
A failure in the regulation of macrophages effector functions can indeed lead to tissue damage 
and chronic disease. Specifically, in the lung a prolonged M1 response accompanied by 
uncontrolled release of cytotoxic or pro-inflammatory mediators can lead to acute injury. On 
the contrary, defects in the M2 functions could induce, through excessive release of fibrogenic 
mediators, chronic disease and fibrosis.  
In addition to a distinct macrophage polarization in C57BL/6 wild type and CD73
-/-
 mice, the 
present work demonstrated for the first time a time-dependent regulation of CD39 and CD73 on 
macrophage surface in response to whole thorax irradiation. While surface expression of CD73 
was reduced on alveolar macrophages at week 3 p.i., a significant increase was found at week 
6, followed by normal expression levels at later time points. On the contrary CD39 surface 
levels were higher at week 3 p.i. when compared to non irradiated controls, reaching normal 
levels at week 6 and gradually increasing again. It is still not clear what is the functional 
relevance of these findings and what drives the distinct regulation of these two ecto-enzymes 
on the surface of macrophages, since they are supposed to act in a concerted manner to produce 
adenosine. However, the results clearly suggest that after irradiation alveolar macrophages 
could represent one of the major players in the production of adenosine, or of intermediate 
components of the adenosinergic pathway, possibly contributing to the development of fibrosis.  
In this scenario, adenosine is known to influence macrophage effector functions, e.g. their 
phagocytic ability, production of ROS/NO (decrease), secretion of tumor necrosis factor α 
(TNF-α) and IL-12, as well as induction of IL-10 (Hasko et al., 2007; Hasko et al., 1996; Xaus 
et al., 1999). In addition, adenosine has been shown to enhance alternative macrophages 
activation in vitro in the presence of IL-4 and IL-13, the two major type 2 cytokines (Barczyk 
et al., 2010; Bours et al., 2006; Csoka et al., 2012), and to prevent excessive classical 
macrophage activation (Hasko and Pacher, 2012). It is also known that polarization of 
peritoneal macrophages is accompanied by differential expression of CD39 and CD73. The M1 
macrophages exhibited a downregulation of CD39 and CD73 resulting in a reduced ATP 
hydrolysis. In contrast, macrophages M2 showed increased ATPase and ADPase activities in 
relation to M1 macrophages (Zanin et al., 2012). Own preliminary experiments confirmed that 
BMDM, which do not express CD73, slightly decrease the expression of CD39 following in 
vitro polarization to M1 by stimulation with LPS and IFN-γ, while they upregulate CD39 
expression when polarized to M2 with IL-4 (data not shown). However, increased expression 
of CD39 after whole thorax irradiation was not associated to the early appearance of M2 
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macrophages in the lung tissue of irradiated mice, suggesting that the in vitro conditions cannot 
mimic the in vivo situation, where macrophages are exposed to complex microenvironmental 
changes in the lung tissue regulating their response to injury. Due to the prominent plasticity 
and the anatomical location of lung macrophages, it is logical to think that they are key players 
in shaping the initial inflammation following exposure to IR and data showed herein suggest 
that the CD73/Ado signalling could be one of the mechanisms used by these cells.  
Up to now, the role of macrophages in radiation-induced pneumopathy has not yet been 
defined. Johnston et al. depleted lung macrophages using clodronate instillation before 15 Gy 
lung irradiation. The obtained temporary depletion of macrophages did not alter the number of 
macrophages and lymphocytes infiltrating the lung 8 weeks p.i. and the increase of 
macrophages at 16 weeks, when compared to irradiated mice not depleted of macrophages. 
Unfortunately no information about the effects of macrophages depletion on fibrosis 
development has been provided in that study (Johnston et al., 2004). Several other studies have 
tried to define a role of macrophages in fibrotic diseases of distinct origin. Clodronate depletion 
of alveolar macrophages led to a markedly reduced fibrotic response in a model of 
silica-induced fibrosis in rats (Elder et al., 2004). In a controlled model of liver fibrosis in rats, 
characterized by distinct phases of injury, repair and resolution, macrophage depletion during 
the progressive inflammatory injury had beneficial effect, ameliorating fibrosis. By contrast, 
the natural resolution of tissue injury after carbon tetrachloride (CCl4) treatment failed when 
depleting macrophages during the recovery phase (Duffield et al., 2005). As it was seen for 
depletion of Treg cells mentioned above, macrophages seem to have a positive role in the 
resolution phase of the inflammatory process. However, macrophages produce many 
chemoattractants and growth factors regulating the wound healing response and interfering 
with those functions can lead to an altered repair process. Consequently, modulation rather than 
eradication of Treg cells and macrophages may be a promising approach for controlling fibrosis. 
 
The dampening of the immune cell response by anti-inflammatory drugs is currently used in the 
clinic to avoid pneumonitis, but this treatment is not sufficient to prevent late side effects of 
lung irradiation. The use of the CD73/Ado system in the prevention or treatment of 
radiation-induced lung injury is of special interest because this immunosuppressive pathway is 
known to promote tumor growth. Thus, inhibition of CD73/Ado may not only have a beneficial 
effect on radiation-induced pneumopathy, but at the same time may improve the efficacy of 
radio(chemo)therapy of lung tumors. 
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Each fibrotic disease, though sharing common features, could differently progress depending 
on the initial injury and on the specific resident, immune, and recruited cells involved in the 
reaction to the provoking stimulus. Therefore it is important to define tissue responses to 
radiation in an in vivo model, and to clarify the role of the immune system in driving 
pneumonitis and, possibly, fibrosis development. The data presented in this PhD thesis for the 
first time cope with the effort of elucidating macrophage and T cell responses to whole thorax 
irradiation through analysis of their phenotype and immunoregulatory functions.  
 
Notably, though the importance of lymphocytes in lung fibrosis development in general has 
been broadly investigated, after more than 30 years of studies, the influence of lymphocytes on 
fibrosis development is still not clear. Therefore, to directly address the role of the lymphocyte 
compartment in radiation-induced fibrosis, RAG-2
-/-
 mice lacking mature T and B lymphocytes 
were analysed in addition. RAG-2
-/-
 mice responded to thorax irradiation with reduced gain in 
weight and a decreased survival rate compared to WT mice, suggesting that the lack of mature 
lymphocytes causes an increased sensitivity to radiation-induced late adverse effects. 
Subsequent histological analyses revealed that RAG-2
-/- 
mice develop pronounced lung fibrosis 
already at 24 weeks p.i. A significantly higher amount of fibrotic foci was detected 24 weeks 
p.i. in these mice when compared to WT mice, though it did not correspond to a significant 
increase in the fibrotic area. Areas of collagen deposition stained also positive for the two 
characteristic fibrosis markers α-SMA and TGF-β corroborating the finding that, in the absence 
of mature T lymphocytes (and B lymphocytes), mice respond to whole thorax irradiation with 
an earlier onset of fibrosis. In support of this observation, the fibrotic response in SCID mice 
receiving intratracheal BLM also occurred earlier when compared to WT animals (Helene et 
al., 1999). Interestingly, the analysis of immune cell infiltrates after whole thorax irradiation (6 
and 24 week p.i.), revealed that in RAG-2
-/-
 mice the scavenger receptor CD36 was highly 
upregulated on alveolar macrophages already at 24 weeks p.i., whereas in WT mice CD36 
expression on alveolar macrophages increased only at 30 weeks p.i.. This suggests that 
expression of CD36 may be a common feature of alveolar macrophages in fibrotic tissues and 
supports the earlier onset of fibrosis in RAG-2
-/-
 mice in the absence of appropriate control of 
the innate immune cells by the adaptive immune system. Whether and how this finding relates 
to the potential alterations in lipid metabolism and macrophage functions needs further 
investigations. 
Surprisingly, RAG-2
-/-
 mice failed to upregulate CD73 on alveolar macrophages at 6 weeks p.i.. 
In contrast, a slightly more pronounced upregulation of CD39 was observed at this time point 
 Discussion 4 
 
 | 97  
 
when compared to WT mice. Although the lack of analyses at other time points does not allow 
a final conclusion, these observations may be indicative for a shift in the response of the 
adenosinergic pathway on macrophages of RAG-2
-/-
 mice to an earlier activation after 
irradiation. Cells isolated from WT mice indeed significantly upregulated CD39 only 
12 weeks p.i.. 
Of note, the extent of macrophage polarization to a pro-inflammatory M1 phenotype was more 
pronounced in irradiated RAG-2
-/-
 mice when compared to irradiated WT mice at both time 
points. These data suggest that mature (regulatory) lymphocytes may be required to keep in 
check activated cells from the innate immune system. Moreover, it could be hypothesized that 
the more intense inflammation may contribute to the earlier onset of fibrosis observed in 
RAG-2
-/-
 mice. Still, further investigations are required to confirm the hypothesis about a faster 
degeneration of the lung tissue in irradiated RAG-2
-/-
 mice.  
In a preliminary experiment RAG-2
-/-
 mice received whole thorax irradiation and 1 day after 
they were adoptively transferred with CD4
+
 T cells isolated from WT mice. These cells indeed 
were the most affected by IR in the previously described experiments. Unfortunately, no 
changes could be seen in late side effects of whole thorax irradiation, in that RAG-2
-/-
 mice and 
reconstituted RAG-2
-/-
 mice showed comparable amount of fibrosis 24 weeks p.i. 
(Supplementary data, Fig. 7.2). These data suggest that the presence of the complete CD4
+
 
T cell population early after whole thorax irradiation is not sufficient to decrease the 
pronounced sensitivity of RAG-2
-/-
 mice to radiation-induced fibrosis. To identify the 
beneficial effect of the adaptive immune system it has to be tested whether adoptive transfer of 
specific T cell subsets, or of B cells, would mimic the delayed response observed in WT mice. 
 
The present work was designed to describe chronological changes in the lung tissue and in the 
innate and adaptive immune systems in response to thorax irradiation as a model for fibrosis 
development resulting from chronic lung injury, in an attempt to identify potential innovative 
therapeutic targets. Overall data obtained in the RAG-2
-/-
 model point to an essential role of the 
adapative immune system in the control of radiation-induced pneumopathy. However, the 
CD4
+
 T cell subset alone seems not to be sufficient to prevent the earlier onset of 
radiation-induced late side effects in the lung tissue. Nevertheless, a complete and functional 
adaptive immune system does not prevent the fibrotic response of the lung tissue after whole 
thorax irradiation either, as demonstrated by the development of lung fibrosis by week 30 p.i. in 
WT mice. However, the adaptive immune system seems to participate in the control of the 
pro-inflammatory phenotype of cells from the innate immune system, thereby decreasing 
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and/or delaying fibrosis development. Therefore it is highly likely that an uncontrolled 
response of the innate immune cell compartment, and possibly above all macrophages, 
extensively contribute to and accelerate the adverse effects of whole thorax irradiation. In this 
extremely complex scenario, it is necessary to consider that other lung resident cells such as 
endothelial, epithelial cells, and fibrocytes will additionally influence the lung 
microenvironment and cooperate with cells of the innate and/or adaptive immune system in 
driving local tissue damage and destruction of the normal lung architecture in response to lung 
irradiation. Understanding the contribution of the different macrophage subsets, of soluble 
mediators secreted by these cells, and of cellular and secreted factors controlling macrophage 
phenotype will help to find novel ways to redirect the radiation-response of the lung tissue 
towards a resolution of early inflammation and reestablishment of tissue homeostasis.  
 
Importantly, the CD73 deficient mouse model used in this study helped to demonstrate for the 
first time a direct role of the CD73/Ado pathway in the progression of late side effects of lung 
irradiation. Data obtained in CD73
-/-
 mice suggest an involvement of the adenosinergic 
pathway in radiation-induced changes in the lung microenvironment, as well as in the 
progression of pneumonitis to lung fibrosis. While CD73 expression on immune cells was 
mostly affected in the early phase, other players, like diffuse tissue hypoxia and increased 
TGF-β, may affect CD73 expression and activity on other resident cells thereby enhancing the 
amount of regulatory T cells and of alternatively activated macrophages to amplify the fibrotic 
response. Of course, to determine whether CD73 on resident cells is required to drive fibrosis, 
CD73 activity and adenosine levels should be measured overtime in the lung tissue and the 
BALF, respectively. Such investigations are also necessary to identify a possible window of 
action for a therapeutic strategy targeting the CD73/Ado system.  
 
In conclusion, the present work clearly demonstrated that inflammation constitutes an 
important process that contributes to the secondary effects of radiation-induced DNA-damage 
in the lung. Therefore it is highly likely that an appropriate orchestration of inflammatory, 
repair and regeneration processes could help to avoid early and late side effects in this 
radiosensitive organ. Of note, complete eradication of specific cell populations from the innate 
or adaptive immune systems seems to worsen radiation-induced late adverse effects. Thus, a 
fine tuning of immune cell activation and polarization, rather than complete suppression of 
specific immune cell populations may be effective in the control of the adverse tissue response 
to radiation. Therefore, the identification of key regulators/mediators of fibrosis like 
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CD73/Ado, and/or of the cells responsible for the generation of such regulators/mediators is of 
utmost importance for developing effective treatment strategies. Because of its dual role in the 
control of tissue inflammation and fibrosis, the CD73/Ado system may be an attractive 
therapeutic target for prevention or treatment of radiation-induced pneumopathy. The benefit of 
inhibitors of CD73 or of adenosine signalling has to be tested in further investigations.  
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5  Summary 
 
Radiation-induced pneumonitis and fibrosis still constitute a major complication in the 
treatment of patients with thorax-associated neoplasms. To date, the molecular mechanisms 
governing the onset and progression of these injuries are not entirely understood and no 
effective therapies are available. Aim of the present study was to gain more insight into the 
pathogenesis of radiation-induced pneumonitis and fibrosis, with the ultimate goal to provide a 
molecular basis for the development of novel and effective strategies for prevention or 
treatment of these pathologies. At this purpose, investigations on immune cells and on the 
immunomodulatory CD73/adenosine system have been performed in vivo in a C57BL/6 mouse 
model of whole thorax irradiation with 15 Gray (Gy). 
In the present work, CD73 was identified as a key mediator of radiation-induced fibrosis, in 
that CD73 deficient mice showed no or minimal fibrosis at 30 weeks post irradiation (p.i.), 
while wild type (WT) mice showed extensive collagen deposition, diffuse hypoxia and fibrotic 
areas positive for α-SMA and TGF-β at this time point. Thus, lack of endogenous CD73 seems 
to exert a radioprotective effect. Of note, the progression to a more pronounced fibrosis in WT 
mice was associated with CD73 upregulation on T cells and macrophages during the 
pneumonitic phase, in addition to an early and late expansion of regulatory T (Treg) cells, both 
locally and systemically. A shift in macrophage phenotype was also noted, with prevalence of 
pro-inflammatory M1 macrophages during the pneumonitic phase, and a subsequent 
polarization into an anti-inflammatory M2 phenotype. Surprisingly, lung macrophages and T 
cells of CD73
-/-
 mice were less sensitive to radiation-induced cell depletion in the tissue. 
Noteworthy, a significantly lower amount of Treg cells was found in irradiated CD73
-/-
 mice as 
compared to WT mice, within the lung tissue and in peripheral lymphoid organs. The shift of 
phenotype was not observed in lung macrophages of CD73
-/- 
mice, and pro-inflammatory M1 
macrophages were still elevated at 30 weeks p.i. In addition, irradiated WT and CD73
-/-
 mice 
displayed a differential regulation of the upstream component of the adenosinergic pathway 
(CD39) on the immune cells analysed. Thus, endogenous presence or absence of CD73 result in 
distinct responses within the lung tissue, determining the progression and the final outcome of 
radiation-induced side effects. 
Remarkably, complete absence of mature B and T cells led to an increased sensitivity to 
radiation-induced fibrosis. Therefore, in WT mice a Treg cell-mediated control of the innate 
immune response might help in delaying the damaging effects of IR. However, 
radiation-induced alterations in the microenvironment, such as chronic upregulation of 
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adenosine, may subsequently influence the phenotype of macrophages and of other resident 
cells to promote extensive remodelling and fibrosis.  
This model provided evidence for a direct involvement of the immune system in the 
pathogenesis of lung radiation-induced pneumopathy. Morevorer, the herein presented work 
underlines the importance of the CD73/adenosine system in the regulation of lung responses to 
IR, therefore it might represent a good target for future combination treatments. 
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7  Appendix 
 
7.1 Supplementary data  
 
7.1.1 Radiation response of regulatory T cells in C57BL/6 wild type mice 
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Fig. 7.1 Determination of local and systemic Treg cells by flow cytometry. C57BL/6 wild type (WT) received 
0 Gy or 15 Gy whole thorax irradiation. Lymphocytes were isolated from lung (A), blood, spleen and cervical 
lymph nodes (LN) (B) at 3, 6, 12, 24 and 30 weeks p.i., and used for flow cytometric measurement of T reg cells. 
Timelines show relative or absolute percentages ± SD of CD4
+
CD25
+
Foxp3
+
 T lymphocyte population in the 
mentioned tissues of WT mice (* p≤0.05; ** p≤0.01; two-tailed unpaired t-test). 
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7.1.2 Effect of CD4+ T cells on fibrosis development 
 
Most of the significant changes in T lymphocytes of irradiated C57BL/6 wild type mice were 
observed in CD4
+
 T cells, therefore to shed light on the contribution of these cells in 
radiation-induced fibrosis, in a preliminary experiment RAG-2
-/- 
mice were adoptively 
transferred with CD4
+
 T cells 1 day after irradiation or control anaesthesia. Single cell 
suspensions were obtained from spleens of C57BL/6 wild type mice and used for magnetic 
separation of CD4
+
 T lymphocytes through negative selection. The spontaneous proliferation 
and generation of memory and effector cells have been already documented after T cell transfer 
in lymphopenic mice (Surh and Sprent, 2008). Blood samples obtained through eye puncture 
from reconstituted mice were subjected over time to flow cytometry to confirm T cell 
persistence also in the radiation model adopted in this study (Fig 7.2 A). Similarly to what 
described before for RAG-2
-/- 
mice, lungs of reconstituted mice were isolated 24 weeks after 
irradiation and processed for histological analysis. As shown in Fig 7.2 B, a similar extent of 
the fibrotic area, as well as a similar amount of fibrotic foci were found in irradiated CD4
+
 
T cell transferred mice compared to irradiated RAG-2
-/- 
mice without adoptive T cell transfer 
(PBS injected).  
These data suggested that the CD4
+
 T cells alone seem to be unable to ameliorate fibrosis 
development in RAG-2
-/- 
after whole thorax irradiation.  
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Fig. 7.2 Fibrosis quantification in RAG-2
-/- 
mice adoptively transferred with CD4
+
 T cells. RAG-2
-/-
 mice 
(RAG2) and RAG-2
-/-
 mice that were adoptively transferred with CD4
+
 T cells (RAG2 + CD4) received 0 Gy or 
15 Gy whole thorax irradiation. Blood samples from all groups were regularly assessed for the presence of CD4
+
 
T cells. At 24 weeks p.i., lung tissue was isolated and used for histological analysis. Paraffin sections obtained 
from irradiated mice were stained with H&E and evaluated for the amount of fibrosis and the number of fibrotic 
foci. A) Blood samples regularly collected were stained with anti-CD4 antibodies. Representative dot plots for 
RAG2
 
mice (left plot) and reconstituted RAG2 mice (right plot) are shown. B) Quantification of fibrosis expressed 
as percentage of fibrotic lung area (left plot), and quantification of the number of fibrotic foci in irradiated mice 24 
weeks after irradiation (right plot). Data represent median values obtained in 3 sections per mouse with a 
minimum distance of 250 µm in depth.  
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7.2 Abbreviations 
 
A 
ACK 
ADA  
Ado  
ADP 
AECI/II  
ALI  
AM  
AMP 
ANOVA 
APAAP 
APC 
Arg1  
ATP 
α-SMA 
 
B 
BALF 
BLM  
BSA 
 
C 
cAMP  
CD 
CO2 
COPD 
CRE  
CREB 
CSF-1 
CSF-1R  
CTL 
Cy2/3/5.5/7 
 
D 
DAB 
DC 
ddH2O 
DEREG 
DMEM 
DNA 
 
E 
EDTA 
EtOH 
 
F 
FACS 
FcR 
 
Ammonium chloride potassium buffer  
Adenosine deaminase 
Adenosine 
Adenosine diphosphate 
Alveolar epithelial cell 
Acute lung injury 
Alveolar macrophages 
Adenosine monophosphate 
Analysis of variance 
Alkaline phosphatase-anti-alkaline phosphatase  
Allophycocyanin or Antigen presenting cell 
Arginase 1 
Adenosine triphosphate 
α-smooth muscle actin 
 
 
Bronchoalveolar lavage fluid 
Bleomycin 
Bovine serum albumin 
 
 
Cyclic AMP 
Cluster of differentiation 
Carbon dioxide 
Chronic obstructive pulmonary disease 
cAMP response element  
CRE binding protein 
Colony stimulating factor 1  
Colony stimulating factor 1 receptor 
Cytotoxic T lymphocytes 
Cyanine dyes 2/3/5.5/7 
 
 
3,3'-diaminobenzidine 
Dendritic cells 
Double distilled water 
Depletion of regulatory T cells 
Dulbecco's modified eagle medium 
Deoxyribonucleic acid 
 
 
Ethylenediaminetetraacetic acid 
Ethanol 
 
 
Fluorescence activated cell sorting 
Fragment crystallizable receptor 
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F  
FCS 
Fig. 
FITC 
Foxp3  
FSC 
 
G 
GM-CSF 
GPI 
Gy 
 
H 
H&E 
HBSS 
HIF-1α 
HRE 
 
I 
i.p.  
i.t.  
IFN  
IgG 
IL  
IM  
iNOS  
IPF  
IR  
 
K 
KHCO3 
 
L 
LDL 
LNC 
LN 
 
M 
M1 
M2 
M-CSF 
MHCII 
MMR 
 
N 
NaCl 
NGS 
NH4Cl 
NK 
NO 
 
 
Fetal calf serum  
Figure  
Fluorescein isothiocyanate 
Forkhead box P3 
Forward-scattered  
 
 
Granulocyte-macrophage colony-stimulating factor 
Glycosyl phosphatidylinositol 
Gray 
 
 
Hematoxylin and eosin 
Hank's balanced salt solution 
Hypoxia inducible factor 1α 
Hypoxia response element 
 
 
Intra peritoneal 
Intra tracheal 
Interferon 
Immunglobulin G 
Interleukin 
Infiltrating macrophages 
Inducible nitric oxide synthase 
Idiopathic pulmonary fibrosis 
Ionizing radiation  
 
 
Potassium bicarbonate 
 
 
Low-density lipoproteins 
Lymph node cell 
Lymph node 
 
 
Classically activated macrophages 
Alternatively activated macrophages 
Macrophage colony-stimulating factor 
Major histocompatibility complex 
Mannose receptor 
 
 
Sodium chloride 
Normal goat serum 
Ammonium chloride 
Natural killer (cells) 
Nitric oxide 
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P 
p.i  
PBMC 
PBS 
PDGF  
PE 
PerCP 
PFA 
 
R 
RAG 
ROS 
rpm 
RPMI 
 
S 
SCID 
SD 
SSC 
 
T 
TBS 
TGF-β 
TH 
TLC 
TMA 
TNF-α 
Treg 
Tris 
TSC 
 
V 
VHL 
 
W 
WT 
 
 
Post irradiation 
Peripheral blood mononuclear cell 
Phosphate buffered saline 
Platelet-derived growth factor 
Phycoerythrin 
Peridinin chlorophyll protein complex 
Paraformaldehyde 
 
 
Recombination activating gene 
Reactive oxygen species  
Rounds per minute 
Roswell park memorial institute medium 1640 
 
 
Severe combined immunodeficiency 
Standard deviation   
Side-scattered 
 
 
Tris buffered saline 
Transforming growth factor β 
T helper (cell) 
Total lung cells 
Tissue micro array 
Tumor necrosis factor α 
Regulatory T (cells) 
Tris(hydroxymethyl) aminomethane  
Total spleen cells 
 
 
von Hippel-Lindau 
 
 
Wild type 
 
 
 
 
 
For volume, mass, time or other physical indications, SI (International System of Units) or  
Legal units were used. 
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